| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | MYH2 MYH3 MYH8 MYH10 CORO2A MYH7B SPTAN1 SPTBN1 MYO18A NEB SYNE3 XIRP2 MACF1 MYH15 PLEC | 1.58e-09 | 227 | 175 | 15 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH2 MYH3 MYH8 MYH10 FMR1 SYNM CORO2A MYH7B SPTAN1 KTN1 SPTBN1 CEP290 LRRK2 MYO18A PACSIN3 TRIM54 APOE NEB CCDC88B SLC4A1 CLIP4 TTBK1 SYNE3 XIRP2 CDK5RAP2 MACF1 MYH15 ABCG2 PLEC DMD GOLGA8A | 7.04e-09 | 1099 | 175 | 31 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYH2 MYH3 MYH8 MYH10 CORO2A MYH7B SPTAN1 SPTBN1 LRRK2 MYO18A NEB SLC4A1 SYNE3 XIRP2 MACF1 MYH15 PLEC DMD | 2.35e-07 | 479 | 175 | 18 | GO:0003779 |
| GeneOntologyMolecularFunction | microfilament motor activity | 9.10e-07 | 38 | 175 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.79e-07 | 118 | 175 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | CUL1 FMR1 SH3RF1 SYNM KSR2 LRRK2 PRPF6 CAMTA2 DZIP1 AIP TRIP11 EMILIN1 SLC4A1 RAD50 OPTN KMT2D SYNE3 AKAP9 TRIM28 TRIM62 TAX1BP1 HELZ2 MED12L TOLLIP AP1G2 VAMP8 FBXL2 ZBED1 MED12 SS18L2 | 2.36e-06 | 1356 | 175 | 30 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | CUL1 FMR1 SH3RF1 SYNM KSR2 LRRK2 PRPF6 CAMTA2 AIP TRIP11 SLC4A1 RAD50 OPTN KMT2D SYNE3 TRIM28 TRIM62 TAX1BP1 HELZ2 MED12L AP1G2 VAMP8 FBXL2 ZBED1 MED12 SS18L2 | 9.69e-06 | 1160 | 175 | 26 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coactivator activity | PRPF6 CAMTA2 AIP TRIP11 KMT2D TRIM28 TRIM62 HELZ2 MED12L ZBED1 MED12 SS18L2 | 1.55e-05 | 303 | 175 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH3 MYH8 MYH10 MYH7B SMC6 MYO18A ATP9B RAD50 LONP1 DNAH12 MDN1 HELZ2 MACF1 MYH15 ABCG2 DNAH9 | 2.97e-05 | 614 | 175 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | structural constituent of muscle | 3.59e-05 | 43 | 175 | 5 | GO:0008307 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYH2 MYH3 MYH8 MYH10 SPTAN1 SPTBN1 RYR3 CDK5RAP2 MYH15 FBXL2 | 3.69e-05 | 230 | 175 | 10 | GO:0005516 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 MYH8 RAP1GAP SMC6 LRRK2 MYO18A ATP9B NKIRAS1 RGS10 RAD50 LONP1 DNAH12 MDN1 HELZ2 RAB7A MACF1 ABCG2 GNG10 DNAH9 | 5.23e-05 | 775 | 175 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 7.64e-05 | 2 | 175 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 7.64e-05 | 2 | 175 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 7.64e-05 | 2 | 175 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 7.64e-05 | 2 | 175 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 MYH8 SMC6 MYO18A ATP9B RAD50 LONP1 DNAH12 MDN1 HELZ2 MACF1 ABCG2 DNAH9 | 1.44e-04 | 441 | 175 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH3 MYH8 RAP1GAP SMC6 LRRK2 MYO18A ATP9B NKIRAS1 RGS10 RAD50 LONP1 DNAH12 MDN1 HELZ2 RAB7A MACF1 ABCG2 GNG10 DNAH9 | 1.48e-04 | 839 | 175 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH3 MYH8 RAP1GAP SMC6 LRRK2 MYO18A ATP9B NKIRAS1 RGS10 RAD50 LONP1 DNAH12 MDN1 HELZ2 RAB7A MACF1 ABCG2 GNG10 DNAH9 | 1.50e-04 | 840 | 175 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH3 MYH8 RAP1GAP SMC6 LRRK2 MYO18A ATP9B NKIRAS1 RGS10 RAD50 LONP1 DNAH12 MDN1 HELZ2 RAB7A MACF1 ABCG2 GNG10 DNAH9 | 1.50e-04 | 840 | 175 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 4.53e-04 | 4 | 175 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 4.53e-04 | 4 | 175 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 7.51e-04 | 5 | 175 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 7.51e-04 | 5 | 175 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 7.51e-04 | 5 | 175 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | ADP binding | 8.21e-04 | 48 | 175 | 4 | GO:0043531 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 9.10e-04 | 85 | 175 | 5 | GO:0017018 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.01e-03 | 130 | 175 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.03e-03 | 23 | 175 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | microtubule binding | FMR1 CEP290 LRRK2 TRIM54 CCDC88B CLIP4 CDK5RAP2 MACF1 GOLGA8A | 1.62e-03 | 308 | 175 | 9 | GO:0008017 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.85e-03 | 28 | 175 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 2.07e-03 | 8 | 175 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 2.07e-03 | 8 | 175 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | structural molecule activity | KRT72 MYH8 KRT17 COL6A6 SYNM DSP SPTAN1 SPTBN1 LAMB3 APOE NEB EMILIN1 TUFT1 KRT80 MACF1 PLEC DMD | 2.19e-03 | 891 | 175 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 2.74e-03 | 109 | 175 | 5 | GO:0004722 | |
| GeneOntologyBiologicalProcess | endomembrane system organization | MYH2 TRAPPC11 MYH10 EMC1 SPTBN1 LRRK2 MYO18A PACSIN3 GOLGA8R TRIP11 SLC4A1 ESYT2 OPTN AKAP9 WASHC5 FER1L4 RAB7A MAFB PLEC COG5 GOLGA8A GOLGB1 DOP1B | 1.10e-08 | 672 | 173 | 23 | GO:0010256 |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | TRAPPC11 SPTBN1 LRRK2 MYO18A ATP9B TRIP11 OPTN VPS52 PPP6C AP1G2 MACF1 COG5 GOLGA8A SNX12 GOLGA4 DOP1B | 2.91e-08 | 339 | 173 | 16 | GO:0048193 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT72 MYH3 MYH10 KRT17 DSP SPTAN1 SPTBN1 TRIM54 APOE NEB CCDC88B EMILIN1 ELMO1 KRT80 CLIP4 SH3PXD2B AKAP9 XIRP2 WASHC5 TENM1 KANK4 CDK5RAP2 PLEC GOLGA8A | 1.59e-06 | 957 | 173 | 24 | GO:0097435 |
| GeneOntologyBiologicalProcess | Golgi organization | TRAPPC11 LRRK2 MYO18A GOLGA8R TRIP11 OPTN AKAP9 COG5 GOLGA8A GOLGB1 | 1.59e-06 | 168 | 173 | 10 | GO:0007030 |
| GeneOntologyBiologicalProcess | organelle localization | TRAPPC11 SNX4 MYH10 CEP290 LRRK2 NCAM1 TRIP11 SPICE1 ESYT2 SYNE3 MDN1 AKAP9 PPP6C MAD1L1 RAB7A CDK5RAP2 DMD VAMP8 GOLGA8A MAD2L1 | 1.95e-06 | 703 | 173 | 20 | GO:0051640 |
| GeneOntologyBiologicalProcess | viral life cycle | FMR1 SMC6 TNFRSF14 NCAM1 TRIM34 APOE RAD50 TRIM28 TRIM62 RAB7A VAMP8 FBXL2 ZBED1 | 6.23e-06 | 340 | 173 | 13 | GO:0019058 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 2.01e-05 | 99 | 173 | 7 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 2.15e-05 | 100 | 173 | 7 | GO:0045103 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 3.74e-05 | 23 | 173 | 4 | GO:0090161 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | RAP1GAP FMR1 TBC1D30 SPTAN1 SPTBN1 LRRK2 PACSIN3 TRIM54 APOE EMILIN1 RAD50 KIAA0319 MCTP1 MAD1L1 KANK4 RAB7A CDK5RAP2 FBXL2 MAD2L1 SMG6 | 3.96e-05 | 864 | 173 | 20 | GO:0051129 |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | FMR1 SMC6 TNFRSF14 NCAM1 TRIM34 APOE RAD50 TRIM62 RAB7A VAMP8 FBXL2 ZBED1 | 4.28e-05 | 351 | 173 | 12 | GO:0044403 |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 6.58e-05 | 119 | 173 | 7 | GO:0006892 | |
| GeneOntologyBiologicalProcess | modulation by host of viral process | 7.40e-05 | 52 | 173 | 5 | GO:0044788 | |
| GeneOntologyBiologicalProcess | microtubule-based process | FMR1 DNAAF4 KTN1 CEP290 TRIM54 APOB DZIP1 CCDC88B QRICH2 SPICE1 CLIP4 DYDC1 DNAH12 AKAP9 WASHC5 CEP250 CDK5RAP2 MACF1 GOLGA8A DNAH9 HYDIN MAD2L1 | 7.90e-05 | 1058 | 173 | 22 | GO:0007017 |
| GeneOntologyBiologicalProcess | modulation by host of viral genome replication | 8.36e-05 | 28 | 173 | 4 | GO:0044827 | |
| GeneOntologyBiologicalProcess | UMP biosynthetic process | 9.11e-05 | 11 | 173 | 3 | GO:0006222 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport to the plasma membrane | 1.04e-04 | 172 | 173 | 8 | GO:0098876 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside monophosphate biosynthetic process | 1.21e-04 | 12 | 173 | 3 | GO:0009174 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SNX4 TBC1D30 SPTAN1 SPTBN1 SMC6 LRRK2 TRIM54 DZIP1 NEB PGAM5 SPICE1 RAD50 SH3PXD2B AKAP9 XIRP2 WASHC5 TRIM28 MAD1L1 TENM1 KANK4 RAB7A CDK5RAP2 CDC25C MAD2L1 SMG6 | 1.44e-04 | 1342 | 173 | 25 | GO:0033043 |
| GeneOntologyBiologicalProcess | viral process | FMR1 SMC6 TNFRSF14 NCAM1 TRIM34 APOE RAD50 TRIM28 TRIM62 RAB7A VAMP8 FBXL2 ZBED1 | 1.54e-04 | 464 | 173 | 13 | GO:0016032 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | SNX4 RAP1GAP FMR1 TBC1D30 SPTAN1 SPTBN1 LRRK2 NCAM1 DZIP1 APOE EMILIN1 SPICE1 SH3PXD2B TTBK1 AKAP9 TRIM28 IQSEC1 TENM1 KANK4 RAB7A CDK5RAP2 MACF1 FBXL2 | 1.58e-04 | 1189 | 173 | 23 | GO:0044087 |
| GeneOntologyBiologicalProcess | plasma membrane organization | 1.93e-04 | 188 | 173 | 8 | GO:0007009 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | TRAPPC11 SNX4 MYH10 LRRK2 TRIP11 SPICE1 SYNE3 MDN1 PPP6C MAD1L1 RAB7A CDK5RAP2 VAMP8 MAD2L1 | 2.15e-04 | 546 | 173 | 14 | GO:0051656 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | TBC1D30 SPTAN1 SPTBN1 LRRK2 TRIM54 RAD50 MAD1L1 KANK4 RAB7A CDK5RAP2 MAD2L1 SMG6 | 2.37e-04 | 421 | 173 | 12 | GO:0010639 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYH3 MYH8 MYH10 DSP MYH7B SPTAN1 SPTBN1 MYO18A NEB ELMO1 SH3PXD2B AKAP9 XIRP2 WASHC5 IQSEC1 TENM1 KANK4 PLEC | 2.44e-04 | 912 | 173 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 2.45e-04 | 15 | 173 | 3 | GO:0030049 | |
| GeneOntologyBiologicalProcess | membrane organization | MYH2 TRAPPC11 MYH10 EMC1 SPTBN1 MYO18A PACSIN3 ATP9B APOE TTPA ELMO1 SLC4A1 SAMD9L PPP6C FER1L4 RAB7A MAFB PLEC VAMP8 | 2.51e-04 | 914 | 173 | 19 | GO:0061024 |
| GeneOntologyBiologicalProcess | UMP metabolic process | 3.00e-04 | 16 | 173 | 3 | GO:0046049 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.14e-04 | 153 | 173 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | SPTAN1 SPTBN1 TRIM54 APOE EMILIN1 SH3PXD2B AKAP9 XIRP2 WASHC5 TENM1 KANK4 CDK5RAP2 | 3.39e-04 | 438 | 173 | 12 | GO:1902903 |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside monophosphate metabolic process | 3.62e-04 | 17 | 173 | 3 | GO:0009173 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 4.21e-04 | 75 | 173 | 5 | GO:0045109 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 4.31e-04 | 18 | 173 | 3 | GO:0033275 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to plasma membrane | 4.47e-04 | 76 | 173 | 5 | GO:0061951 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 5.05e-04 | 217 | 173 | 8 | GO:0006941 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside monophosphate biosynthetic process | 5.09e-04 | 19 | 173 | 3 | GO:0009130 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane protein transport | 5.45e-04 | 45 | 173 | 4 | GO:0043001 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 5.84e-04 | 278 | 173 | 9 | GO:0031503 | |
| GeneOntologyCellularComponent | myosin filament | 1.04e-09 | 25 | 174 | 7 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 2.51e-09 | 28 | 174 | 7 | GO:0016460 | |
| GeneOntologyCellularComponent | myofibril | MYH2 MYH3 MYH8 SYNM MYH7B SPTAN1 SPTBN1 TRIM54 NEB RYR3 SLC4A1 XIRP2 MYH15 PLEC DMD | 9.76e-09 | 273 | 174 | 15 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH2 MYH3 MYH8 SYNM MYH7B SPTAN1 SPTBN1 TRIM54 NEB RYR3 SLC4A1 XIRP2 MYH15 PLEC DMD | 2.19e-08 | 290 | 174 | 15 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | MYH2 MYH3 MYH8 SYNM SPTAN1 SPTBN1 TRIM54 NEB RYR3 SLC4A1 XIRP2 PLEC DMD | 1.77e-07 | 249 | 174 | 13 | GO:0030017 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT72 MYH2 MYH3 MYH8 MYH10 KRT17 SYNM DSP MYH7B SPTAN1 SPTBN1 MYO18A TRIM54 APOE NEB RYR3 KRT80 SLC4A1 CLIP4 DNAH12 XIRP2 CDK5RAP2 MACF1 MYH15 PLEC DMD GOLGA8A DNAH9 | 4.99e-07 | 1179 | 174 | 28 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT72 MYH2 MYH3 MYH8 MYH10 KRT17 SYNM DSP MYH7B SPTAN1 SPTBN1 MYO18A TRIM54 APOE NEB RYR3 KRT80 SLC4A1 CLIP4 DNAH12 XIRP2 CDK5RAP2 MACF1 MYH15 PLEC DMD GOLGA8A DNAH9 | 5.71e-07 | 1187 | 174 | 28 | GO:0099081 |
| GeneOntologyCellularComponent | myosin complex | 5.81e-07 | 59 | 174 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | LRRK2 MYO18A PACSIN3 GOLGA8R ATP9B OPTN VPS52 AKAP9 SCOC AP1G2 COG5 GOLGA8A GOLGA4 GOLGB1 DOP1B | 4.76e-06 | 443 | 174 | 15 | GO:0098791 |
| GeneOntologyCellularComponent | Z disc | 5.00e-06 | 151 | 174 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 1.08e-05 | 166 | 174 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | trans-Golgi network | LRRK2 MYO18A PACSIN3 ATP9B OPTN VPS52 SCOC AP1G2 COG5 GOLGA4 DOP1B | 5.36e-05 | 306 | 174 | 11 | GO:0005802 |
| GeneOntologyCellularComponent | mitotic spindle assembly checkpoint MAD1-MAD2 complex | 6.89e-05 | 2 | 174 | 2 | GO:1990728 | |
| GeneOntologyCellularComponent | chylomicron remnant | 6.89e-05 | 2 | 174 | 2 | GO:0034360 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | FMR1 SH3RF1 UACA ATP9B RYR3 RAD50 OPTN VPS52 TTBK1 CEP250 TENM1 TOLLIP CDK5RAP2 GALNT6 PLEC DMD VAMP8 CDC25C GOLGA8A MAD2L1 | 1.04e-04 | 934 | 174 | 20 | GO:0048471 |
| GeneOntologyCellularComponent | endosome | SNX4 RAP1GAP LRRK2 PACSIN3 ATP9B APOB APOE TTPA KIAA0319 OPTN VPS52 SAMD9L MCTP1 WASHC5 SCOC ANGPTL3 RAB7A TOLLIP AP1G2 VAMP8 SNX12 RNF133 DOP1B | 1.08e-04 | 1167 | 174 | 23 | GO:0005768 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.37e-04 | 230 | 174 | 9 | GO:0098562 | |
| GeneOntologyCellularComponent | muscle myosin complex | 2.93e-04 | 16 | 174 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 MYH3 MYH8 MYH10 MYH7B SPTAN1 SPTBN1 MYO18A NEB SH3PXD2B XIRP2 MACF1 MYH15 FYB1 | 3.43e-04 | 576 | 174 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 3.71e-04 | 263 | 174 | 9 | GO:0045111 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 4.22e-04 | 18 | 174 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | neuronal cell body | MYH10 RAP1GAP FMR1 RASGRF1 LRRK2 NCAM1 GRIA4 APOB APOE RGS10 OPTN TTBK1 AKAP9 WASHC5 DMD GOLGA8A GNRH1 | 6.24e-04 | 835 | 174 | 17 | GO:0043025 |
| GeneOntologyCellularComponent | intermediate filament | 6.47e-04 | 227 | 174 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | cis-Golgi network | 7.23e-04 | 85 | 174 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | early endosome | SNX4 RAP1GAP APOB APOE KIAA0319 SAMD9L WASHC5 ANGPTL3 TOLLIP VAMP8 SNX12 DOP1B | 7.26e-04 | 481 | 174 | 12 | GO:0005769 |
| GeneOntologyCellularComponent | costamere | 7.77e-04 | 22 | 174 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 9.31e-04 | 185 | 174 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | multivesicular body, internal vesicle | 1.01e-03 | 6 | 174 | 2 | GO:0097487 | |
| GeneOntologyCellularComponent | intermediate-density lipoprotein particle | 1.01e-03 | 6 | 174 | 2 | GO:0034363 | |
| GeneOntologyCellularComponent | microtubule organizing center | CCDC14 TRAF5 TBC1D30 DNAAF4 CEP290 MYO18A DZIP1 TEX9 CCDC88B SPICE1 PPP4C AKAP9 CEP112 CEP250 MAD1L1 CDK5RAP2 ZBED1 | 1.76e-03 | 919 | 174 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | cell body | MYH10 RAP1GAP FMR1 RASGRF1 LRRK2 NCAM1 GRIA4 APOB APOE RGS10 OPTN TTBK1 AKAP9 WASHC5 DMD GOLGA8A GNRH1 | 1.98e-03 | 929 | 174 | 17 | GO:0044297 |
| GeneOntologyCellularComponent | centrosome | CCDC14 TRAF5 DNAAF4 CEP290 DZIP1 TEX9 CCDC88B SPICE1 PPP4C AKAP9 CEP112 CEP250 MAD1L1 CDK5RAP2 ZBED1 | 2.01e-03 | 770 | 174 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | spectrin | 2.39e-03 | 9 | 174 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.67e-03 | 114 | 174 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | Golgi membrane | RAP1GAP LRRK2 MYO18A NCAM1 TRIP11 OPTN SCOC AP1G2 GALNT6 COG5 GOLGA8A GOLGA4 GOLGB1 DOP1B | 2.90e-03 | 721 | 174 | 14 | GO:0000139 |
| GeneOntologyCellularComponent | vesicle tethering complex | 3.07e-03 | 72 | 174 | 4 | GO:0099023 | |
| MousePheno | abnormal intracellular organelle morphology | FMR1 KRT17 CEP290 LRRK2 TRIP11 PGAM5 SLC4A1 LONP1 PPP4C CLCN7 CEP250 MAD1L1 RAB7A CDK5RAP2 CFAP119 ABCG2 GOLGA8A MAD2L1 | 9.50e-06 | 546 | 141 | 18 | MP:0014239 |
| Domain | Myosin_tail_1 | 1.58e-10 | 18 | 174 | 7 | PF01576 | |
| Domain | Myosin_tail | 1.58e-10 | 18 | 174 | 7 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 2.47e-10 | 19 | 174 | 7 | IPR027401 | |
| Domain | - | 2.47e-10 | 19 | 174 | 7 | 4.10.270.10 | |
| Domain | Myosin_N | 2.80e-09 | 15 | 174 | 6 | PF02736 | |
| Domain | Myosin_N | 2.80e-09 | 15 | 174 | 6 | IPR004009 | |
| Domain | Spectrin_repeat | 7.09e-09 | 29 | 174 | 7 | IPR002017 | |
| Domain | SPEC | 1.49e-08 | 32 | 174 | 7 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.49e-08 | 32 | 174 | 7 | IPR018159 | |
| Domain | IQ | MYH2 MYH3 MYH8 MYH10 RASGRF1 MYH7B MYO18A CAMTA2 IQSEC1 MYH15 | 1.58e-08 | 93 | 174 | 10 | PS50096 |
| Domain | Myosin_head_motor_dom | 5.34e-08 | 38 | 174 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.34e-08 | 38 | 174 | 7 | PS51456 | |
| Domain | Myosin_head | 5.34e-08 | 38 | 174 | 7 | PF00063 | |
| Domain | MYSc | 5.34e-08 | 38 | 174 | 7 | SM00242 | |
| Domain | IQ_motif_EF-hand-BS | 1.59e-07 | 90 | 174 | 9 | IPR000048 | |
| Domain | IQ | 3.12e-07 | 71 | 174 | 8 | PF00612 | |
| Domain | IQ | 8.71e-07 | 81 | 174 | 8 | SM00015 | |
| Domain | Spectrin | 1.95e-06 | 23 | 174 | 5 | PF00435 | |
| Domain | - | 1.56e-05 | 6 | 174 | 3 | 3.90.1290.10 | |
| Domain | Plectin | 2.71e-05 | 7 | 174 | 3 | PF00681 | |
| Domain | Plectin_repeat | 2.71e-05 | 7 | 174 | 3 | IPR001101 | |
| Domain | PLEC | 2.71e-05 | 7 | 174 | 3 | SM00250 | |
| Domain | P-loop_NTPase | MYH2 MYH3 MYH8 MYH10 MYH7B SMC6 LRRK2 MYO18A UCK1 NKIRAS1 RAD50 LONP1 SAMD9L DNAH12 MDN1 HELZ2 RAB7A MYH15 ABCG2 DNAH9 HYDIN | 4.30e-05 | 848 | 174 | 21 | IPR027417 |
| Domain | ACTININ_2 | 5.61e-05 | 23 | 174 | 4 | PS00020 | |
| Domain | ACTININ_1 | 5.61e-05 | 23 | 174 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.61e-05 | 23 | 174 | 4 | IPR001589 | |
| Domain | Med12 | 8.63e-05 | 2 | 174 | 2 | PF09497 | |
| Domain | Mediator_Med12_catenin-bd | 8.63e-05 | 2 | 174 | 2 | IPR021989 | |
| Domain | Med12-PQL | 8.63e-05 | 2 | 174 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 8.63e-05 | 2 | 174 | 2 | PF12145 | |
| Domain | Med12 | 8.63e-05 | 2 | 174 | 2 | SM01281 | |
| Domain | Mediator_Med12 | 8.63e-05 | 2 | 174 | 2 | IPR019035 | |
| Domain | Mediator_Med12_LCEWAV | 8.63e-05 | 2 | 174 | 2 | IPR021990 | |
| Domain | PQQ_2 | 8.63e-05 | 2 | 174 | 2 | PF13360 | |
| Domain | Anion_exchange_CS | 2.57e-04 | 3 | 174 | 2 | IPR018241 | |
| Domain | ATPase_dyneun-rel_AAA | 2.68e-04 | 14 | 174 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.68e-04 | 14 | 174 | 3 | PF07728 | |
| Domain | Anion_exchange | 8.47e-04 | 5 | 174 | 2 | IPR001717 | |
| Domain | PQQ_repeat | 1.26e-03 | 6 | 174 | 2 | IPR002372 | |
| Domain | - | 1.26e-03 | 6 | 174 | 2 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 1.26e-03 | 6 | 174 | 2 | IPR027295 | |
| Domain | ANION_EXCHANGER_2 | 1.76e-03 | 7 | 174 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 1.76e-03 | 7 | 174 | 2 | PS00219 | |
| Domain | RING | 2.29e-03 | 305 | 174 | 9 | SM00184 | |
| Domain | AAA | 2.32e-03 | 144 | 174 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 2.32e-03 | 144 | 174 | 6 | IPR003593 | |
| Domain | RecF/RecN/SMC_N | 2.33e-03 | 8 | 174 | 2 | IPR003395 | |
| Domain | SMC_N | 2.33e-03 | 8 | 174 | 2 | PF02463 | |
| Domain | - | 2.98e-03 | 9 | 174 | 2 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 2.98e-03 | 9 | 174 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 2.98e-03 | 9 | 174 | 2 | PF07565 | |
| Domain | CH | 3.17e-03 | 65 | 174 | 4 | SM00033 | |
| Domain | Znf_RING | 3.56e-03 | 326 | 174 | 9 | IPR001841 | |
| Domain | PTrfase/Anion_transptr | 3.70e-03 | 10 | 174 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 3.70e-03 | 10 | 174 | 2 | IPR003020 | |
| Domain | HCO3_cotransp | 3.70e-03 | 10 | 174 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 3.70e-03 | 10 | 174 | 2 | IPR011531 | |
| Domain | CH | 4.14e-03 | 70 | 174 | 4 | PF00307 | |
| Domain | SH3 | 4.19e-03 | 216 | 174 | 7 | PS50002 | |
| Domain | - | SMC6 LRRK2 MYO18A UCK1 NKIRAS1 RAD50 LONP1 SAMD9L DNAH12 MDN1 HELZ2 RAB7A ABCG2 DNAH9 HYDIN | 4.27e-03 | 746 | 174 | 15 | 3.40.50.300 |
| Domain | Filament | 4.35e-03 | 71 | 174 | 4 | SM01391 | |
| Domain | - | 4.35e-03 | 71 | 174 | 4 | 1.10.418.10 | |
| Domain | - | 4.35e-03 | 71 | 174 | 4 | 4.10.45.10 | |
| Domain | Pribosyltran | 4.49e-03 | 11 | 174 | 2 | PF00156 | |
| Domain | zf-B_box | 4.58e-03 | 72 | 174 | 4 | PF00643 | |
| Domain | IF | 4.58e-03 | 72 | 174 | 4 | PS00226 | |
| Domain | SH3_domain | 4.62e-03 | 220 | 174 | 7 | IPR001452 | |
| Domain | CH | 4.81e-03 | 73 | 174 | 4 | PS50021 | |
| Domain | Filament | 4.81e-03 | 73 | 174 | 4 | PF00038 | |
| Domain | zf-C3HC4 | 4.98e-03 | 223 | 174 | 7 | PF00097 | |
| Domain | CH-domain | 5.29e-03 | 75 | 174 | 4 | IPR001715 | |
| Domain | GRIP_dom | 5.36e-03 | 12 | 174 | 2 | IPR000237 | |
| Domain | GRIP | 5.36e-03 | 12 | 174 | 2 | PS50913 | |
| Domain | PRTase-like | 5.36e-03 | 12 | 174 | 2 | IPR029057 | |
| Domain | PRibTrfase_dom | 5.36e-03 | 12 | 174 | 2 | IPR000836 | |
| Domain | - | 5.36e-03 | 12 | 174 | 2 | 3.40.50.2020 | |
| Domain | Znf_C3HC4_RING-type | 5.54e-03 | 172 | 174 | 6 | IPR018957 | |
| Domain | IF | 5.55e-03 | 76 | 174 | 4 | IPR001664 | |
| Domain | ZF_RING_1 | 6.04e-03 | 291 | 174 | 8 | PS00518 | |
| Domain | PP2Ac | 6.29e-03 | 13 | 174 | 2 | SM00156 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 6.29e-03 | 13 | 174 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 6.29e-03 | 13 | 174 | 2 | PS00125 | |
| Domain | ZF_BBOX | 6.64e-03 | 80 | 174 | 4 | PS50119 | |
| Domain | ZF_RING_2 | 6.94e-03 | 298 | 174 | 8 | PS50089 | |
| Domain | Znf_B-box | 6.94e-03 | 81 | 174 | 4 | IPR000315 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.30e-03 | 14 | 174 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 7.30e-03 | 14 | 174 | 2 | IPR013602 | |
| Domain | DHC_N2 | 7.30e-03 | 14 | 174 | 2 | PF08393 | |
| Domain | AAA_8 | 7.30e-03 | 14 | 174 | 2 | PF12780 | |
| Domain | PX | 7.95e-03 | 44 | 174 | 3 | SM00312 | |
| Domain | DHC_fam | 8.37e-03 | 15 | 174 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 8.37e-03 | 15 | 174 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 8.37e-03 | 15 | 174 | 2 | IPR004273 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 3.39e-06 | 70 | 129 | 7 | M12294 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | TRAPPC11 SPTAN1 SPTBN1 PACSIN3 APOB APOE TRIP11 KIAA0319 OPTN VPS52 PPP6C SCOC RAB7A AP1G2 VAMP8 COG5 GOLGA8A GOLGA4 GOLGB1 | 6.21e-06 | 645 | 129 | 19 | MM15232 |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 2.33e-05 | 19 | 129 | 4 | M41732 | |
| Pathway | WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS | 4.84e-05 | 44 | 129 | 5 | M46452 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | TRAPPC11 SPTAN1 SPTBN1 PACSIN3 APOB TRIP11 KIAA0319 OPTN VPS52 PPP6C SCOC RAB7A AP1G2 VAMP8 COG5 GOLGA4 GOLGB1 | 6.05e-05 | 630 | 129 | 17 | M11480 |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 7.29e-05 | 25 | 129 | 4 | MM15562 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | TRAPPC11 SPTAN1 SPTBN1 PACSIN3 APOB APOE TRIP11 KIAA0319 OPTN VPS52 PPP6C SCOC RAB7A AP1G2 VAMP8 COG5 GOLGA4 GOLGB1 | 1.05e-04 | 725 | 129 | 18 | M27507 |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 1.16e-04 | 28 | 129 | 4 | M41724 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 1.27e-04 | 85 | 129 | 6 | MM14906 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 1.44e-04 | 87 | 129 | 6 | M27194 | |
| Pathway | KEGG_TIGHT_JUNCTION | 2.09e-04 | 132 | 129 | 7 | M11355 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 2.51e-04 | 34 | 129 | 4 | M27842 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 2.81e-04 | 35 | 129 | 4 | MM15005 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 2.88e-04 | 184 | 129 | 8 | MM15145 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 3.14e-04 | 36 | 129 | 4 | M18647 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 3.88e-04 | 38 | 129 | 4 | M39549 | |
| Pathway | REACTOME_CELL_CYCLE | CUL1 CENPN POLA1 CEP290 RAD50 OPTN FBXL18 AKAP9 PPP6C CEP250 MAD1L1 CDK5RAP2 CDC25C GOLGA8A MAD2L1 | 4.04e-04 | 603 | 129 | 15 | MM14635 |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 5.03e-04 | 200 | 129 | 8 | M864 | |
| Pathway | BIOCARTA_PDZS_PATHWAY | 5.52e-04 | 18 | 129 | 3 | M22001 | |
| Pathway | REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK | 7.46e-04 | 45 | 129 | 4 | MM15355 | |
| Pathway | REACTOME_CHYLOMICRON_CLEARANCE | 8.16e-04 | 5 | 129 | 2 | MM15564 | |
| Pathway | REACTOME_CHYLOMICRON_CLEARANCE | 8.16e-04 | 5 | 129 | 2 | M27845 | |
| Pubmed | MYH3 MYH8 FMR1 KRT17 UACA DSP KTN1 SPTBN1 TRIM54 DZIP1 NEB SUCLG2 TRIP11 CLIP4 OPTN GSDME AKAP9 XIRP2 TAX1BP1 MED12L CDK5RAP2 MACF1 PLEC | 1.64e-15 | 497 | 179 | 23 | 23414517 | |
| Pubmed | CCDC14 MYH10 SH3RF1 KRT17 DSP SPTAN1 KTN1 SPTBN1 CEP290 MYO18A NEB CCDC88B NSD3 TRIM28 CEP250 MCM3AP TOLLIP MACF1 PLEC DMD COG5 GOLGB1 | 1.10e-14 | 486 | 179 | 22 | 20936779 | |
| Pubmed | MYH10 FMR1 UACA SPTAN1 KTN1 SPTBN1 KSR2 NCAM1 GRIA4 TRIP11 PGAM5 SPICE1 RAD50 KIAA0319 SH3PXD2B MDN1 AKAP9 PPP6C TRIM28 TAX1BP1 MAD1L1 IQSEC1 RAB7A CDK5RAP2 MACF1 GOLGA8A GOLGA4 GOLGB1 SMG6 | 1.89e-14 | 963 | 179 | 29 | 28671696 | |
| Pubmed | CCDC14 SNX4 MYH10 EMC1 KRT17 DSP SPTAN1 SPTBN1 CEP290 MTMR1 AIP NSD3 SPICE1 ESYT2 LONP1 KMT2D PPP4C AKAP9 PPP6C CLCN7 WASHC5 CDK5RAP2 DMD CDC25C CCDC86 GOLGA4 MAD2L1 | 6.30e-12 | 1049 | 179 | 27 | 27880917 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAP1GAP EMC1 SH3RF1 DSP SPTAN1 SPTBN1 DZIP1 TRIP11 NSD3 SPICE1 ESYT2 SH3PXD2B OPTN MDN1 AKAP9 CEP112 MAD1L1 IQSEC1 MACF1 PLEC CDC25C GOLGA4 GOLGB1 DOP1B | 2.06e-11 | 861 | 179 | 24 | 36931259 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | PDXDC1 KRT72 MYH2 MYH3 MYH8 MYH10 DSC1 DSP MYH7B SPTAN1 SPTBN1 MYO18A LAMB3 SUCLG2 KRT80 ESYT2 MDN1 TRIM28 TAX1BP1 PLEC | 1.83e-10 | 647 | 179 | 20 | 26618866 |
| Pubmed | FMR1 DSP NEB PGAM5 RAD50 KMT2D MDN1 CEP250 MACF1 UMPS PLEC DMD GOLGB1 | 3.08e-10 | 234 | 179 | 13 | 36243803 | |
| Pubmed | KRT72 MYH2 MYH3 MYH8 MYH10 KRT17 DSP MYH7B SPTAN1 KTN1 SPTBN1 MYO18A GRIA4 APOB PRPF6 NEB SLC4A3 PGAM5 CCDC182 MDN1 CEP112 GLUD2 TENM1 MACF1 MYH15 PLEC DMD LRMDA GOLGB1 | 3.39e-10 | 1442 | 179 | 29 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CUL1 MYH10 DSC1 PLEKHG4 DSP POLA1 SPTAN1 KTN1 SPTBN1 PRPF6 SUCLG2 PGAM5 RAD50 LONP1 MDN1 FBXL18 PPP6C WASHC5 TRIM28 MCM3AP IQSEC1 RAB7A AP1G2 MACF1 PLEC CCDC86 MED12 GOLGA4 | 3.75e-10 | 1353 | 179 | 28 | 29467282 |
| Pubmed | MYH10 RAP1GAP DSC1 KRT17 DSP SPTAN1 SPTBN1 MYO18A LAMB3 PRPF6 PGAM5 KRT80 ESYT2 MACF1 PLEC DMD | 5.80e-09 | 488 | 179 | 16 | 31324722 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CUL1 COL6A6 KTN1 SPTBN1 PRPF6 APOE NEB RYR3 DNAH12 PPP4C MDN1 XIRP2 TSEN34 TMEM109 HYDIN MED12 | 7.50e-09 | 497 | 179 | 16 | 36774506 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.33e-08 | 120 | 179 | 9 | 31413325 | |
| Pubmed | TRAF5 PLEKHG4 KTN1 CEP290 LRRK2 LAMB3 GRIA4 UPRT TRIP11 ELMO1 SAMD9L SYNE3 ANGPTL3 ABCG2 FBXL2 HYDIN GOLGA4 AKAP7 | 1.97e-08 | 686 | 179 | 18 | 29987050 | |
| Pubmed | CCDC14 CUL1 SNX4 SH3RF1 POLA1 CEP290 PACSIN3 MTMR1 NSD3 CLIP4 ESYT2 LONP1 SYNE3 MDN1 AKAP9 EXOC3L4 CDK5RAP2 UMPS | 2.10e-08 | 689 | 179 | 18 | 36543142 | |
| Pubmed | CUL1 MYH10 FMR1 UACA DSP SPTAN1 KTN1 SPTBN1 RDH10 PACSIN3 APOB PRPF6 AIP SUCLG2 PGAM5 AKAP9 PPP6C TAX1BP1 MCM3AP HELZ2 IQSEC1 RAB7A UMPS PLEC CCDC86 | 4.34e-08 | 1371 | 179 | 25 | 36244648 | |
| Pubmed | MYH10 FMR1 DSP POLA1 SPTAN1 SPTBN1 PRPF6 PGAM5 RAD50 LONP1 MDN1 MCM3AP HELZ2 MACF1 PLEC CCDC86 MED12 | 5.56e-08 | 653 | 179 | 17 | 22586326 | |
| Pubmed | PDXDC1 SNX4 EMC1 KTN1 TRIP11 ESYT2 CLCN7 WASHC5 TENM1 RAB7A VAMP8 GOLGA4 GOLGB1 MAD2L1 DOP1B | 6.28e-08 | 504 | 179 | 15 | 34432599 | |
| Pubmed | KRT72 MYH10 RAP1GAP FMR1 CORO2A DSP SPTAN1 KTN1 SPTBN1 MYO18A MTMR1 NCAM1 APOE TRIP11 SLC4A1 LONP1 WASHC5 TRIM28 GLUD2 IQSEC1 RAB7A TOLLIP MACF1 PLEC DMD | 9.83e-08 | 1431 | 179 | 25 | 37142655 | |
| Pubmed | Genetic contribution of CYP2C9, CYP2C19, and APOE variants in acenocoumarol response. | 1.34e-07 | 3 | 179 | 3 | 24222221 | |
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 1.67e-07 | 25 | 179 | 5 | 30309841 | |
| Pubmed | EMC1 UACA SYNM SPTAN1 KTN1 SPTBN1 MYO18A MTMR1 PRPF6 DZIP1 AIP PGAM5 SPICE1 ESYT2 SYNE3 MDN1 AKAP9 PPP6C CLCN7 RAB7A CDK5RAP2 MACF1 VAMP8 GOLGA4 GOLGB1 | 2.02e-07 | 1487 | 179 | 25 | 33957083 | |
| Pubmed | PDXDC1 CUL1 MYH10 POLA1 SPTAN1 SPTBN1 PRPF6 PGAM5 RAD50 ESYT2 LONP1 MDN1 TRIM28 RAB7A UMPS PLEC | 2.30e-07 | 638 | 179 | 16 | 33239621 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CUL1 DSP SPTAN1 SPTBN1 PRPF6 RAD50 GSDME MDN1 MAD1L1 MED12L MACF1 UMPS PLEC SNX12 GOLGB1 | 3.95e-07 | 582 | 179 | 15 | 20467437 |
| Pubmed | MYH10 SYNM SPTAN1 KTN1 SPTBN1 TRIP11 OPTN TRIM28 MACF1 PLEC GOLGA4 GOLGB1 | 4.16e-07 | 360 | 179 | 12 | 33111431 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | EMC1 UACA POLA1 CEP290 MYO18A RAD50 CLIP4 MDN1 AKAP9 CEP112 CEP250 RAB7A TOLLIP CDK5RAP2 VAMP8 CCDC86 GOLGB1 | 4.21e-07 | 754 | 179 | 17 | 33060197 |
| Pubmed | CUL1 MYH2 MYH10 EMC1 UACA CORO2A SPTAN1 KTN1 SPTBN1 PACSIN3 PRPF6 SUCLG2 PGAM5 RAD50 ESYT2 LONP1 OPTN PPP4C MDN1 PPP6C TRIM28 UMPS TMEM109 COG5 | 4.25e-07 | 1440 | 179 | 24 | 30833792 | |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | EMC1 POLA1 CLIP4 MDN1 AKAP9 CEP112 CEP250 RAB7A CDK5RAP2 CCDC86 GOLGB1 | 4.71e-07 | 298 | 179 | 11 | 32353859 |
| Pubmed | MYH10 EMC1 FMR1 DSP SPTAN1 KTN1 SPTBN1 MYO18A NCAM1 GRIA4 ESYT2 LONP1 WASHC5 TRIM28 GLUD2 IQSEC1 TENM1 RAB7A MACF1 PLEC AKAP7 | 4.80e-07 | 1139 | 179 | 21 | 36417873 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 20357587 | ||
| Pubmed | CCDC14 POLA1 SPTAN1 VPS52 PPP4C PPP6C WASHC5 TSEN34 MED12 MAD2L1 | 5.70e-07 | 242 | 179 | 10 | 34011540 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT72 MYH10 FMR1 DSC1 KRT17 UACA SYNM CORO2A DSP SPTAN1 SPTBN1 MYO18A PACSIN3 LAMB3 PRPF6 PGAM5 KRT80 NSD3 RAD50 TRIM28 HELZ2 PLEC | 6.00e-07 | 1257 | 179 | 22 | 36526897 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UACA DSP SPTAN1 SPTBN1 MYO18A SPICE1 RAD50 ESYT2 KMT2D MDN1 TRIM28 MAD1L1 HELZ2 IQSEC1 PLEC CCDC86 GOLGA4 | 6.04e-07 | 774 | 179 | 17 | 15302935 |
| Pubmed | RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma. | 8.27e-07 | 62 | 179 | 6 | 35568845 | |
| Pubmed | MYH10 DSC1 KRT17 DSP SPTAN1 KTN1 SPTBN1 NCAM1 PGAM5 TRIM28 RAB7A | 9.47e-07 | 320 | 179 | 11 | 28685749 | |
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 9.69e-07 | 146 | 179 | 8 | 20686565 | |
| Pubmed | 9.69e-07 | 146 | 179 | 8 | 21399614 | ||
| Pubmed | 1.02e-06 | 147 | 179 | 8 | 16959763 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.19e-06 | 104 | 179 | 7 | 31240132 | |
| Pubmed | Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. | 1.20e-06 | 66 | 179 | 6 | 20679960 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SH3RF1 SZT2 KSR2 RDH10 LAMB3 NSD3 SH3PXD2B KMT2D SYNE3 MDN1 CLCN7 TRIM28 MCM3AP MAD1L1 HELZ2 AP1G2 PLEC VAMP8 MED12 SMG6 | 1.22e-06 | 1105 | 179 | 20 | 35748872 |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.33e-06 | 5 | 179 | 3 | 3829126 | |
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 20207952 | ||
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 6196357 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT72 MYH10 KRT17 DSP SPTAN1 SPTBN1 CEP290 TRIM28 EXOC3L4 GLUD2 PLEC GOLGA4 GOLGB1 MAD2L1 | 1.52e-06 | 564 | 179 | 14 | 21565611 |
| Pubmed | 1.64e-06 | 272 | 179 | 10 | 31010829 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | DNAAF4 LAMB3 UCK1 APOE TEX9 KHDC4 EMILIN1 DYDC1 OPTN VPS52 PPP6C TAX1BP1 MAD1L1 UMPS DMD COG5 | 1.67e-06 | 742 | 179 | 16 | 26871637 |
| Pubmed | 1.71e-06 | 39 | 179 | 5 | 38690566 | ||
| Pubmed | CUL1 MYH10 DSP POLA1 SPTAN1 SPTBN1 PRPF6 RAD50 WASHC5 TRIM28 RAB7A | 1.71e-06 | 340 | 179 | 11 | 24332808 | |
| Pubmed | RAP1GAP SH3RF1 TBC1D30 UACA SYNM KTN1 CEP290 KHDC4 SAMD9L TTBK1 HELZ2 MACF1 MED12 | 1.88e-06 | 493 | 179 | 13 | 15368895 | |
| Pubmed | FMR1 DSC1 DSP SPTAN1 SPTBN1 SMC6 MYO18A APOB TRIP11 EMILIN1 RAD50 GLUD2 RAB7A DMD TMEM109 GOLGB1 | 2.05e-06 | 754 | 179 | 16 | 35906200 | |
| Pubmed | 2.41e-06 | 284 | 179 | 10 | 29459677 | ||
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 2.65e-06 | 6 | 179 | 3 | 10077619 | |
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 10444070 | ||
| Pubmed | Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion. | 2.65e-06 | 6 | 179 | 3 | 25954050 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 2.65e-06 | 6 | 179 | 3 | 10588881 | |
| Pubmed | FMR1 KTN1 CEP290 MYO18A NCAM1 PRPF6 APOE CCDC88B ELMO1 RAD50 ESYT2 LONP1 SYNE3 MDN1 CLCN7 HELZ2 IQSEC1 COG5 MED12 GOLGB1 | 2.82e-06 | 1168 | 179 | 20 | 19946888 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYH10 NPTX2 EMC1 DSP SPTAN1 SPTBN1 MYO18A MTMR1 PRPF6 PGAM5 NSD3 TRIM28 HELZ2 IQSEC1 RAB7A MACF1 PLEC CCDC86 MED12 | 3.54e-06 | 1082 | 179 | 19 | 38697112 |
| Pubmed | 4.62e-06 | 22 | 179 | 4 | 24301466 | ||
| Pubmed | 4.62e-06 | 7 | 179 | 3 | 35210422 | ||
| Pubmed | 4.62e-06 | 7 | 179 | 3 | 16819597 | ||
| Pubmed | KRT72 CUL1 MYH10 KRT17 SYNM POLA1 SPTAN1 KTN1 SPTBN1 MDN1 PPP6C MACF1 DMD | 4.85e-06 | 538 | 179 | 13 | 28524877 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CCDC14 CUL1 MYH2 MYH10 DSC1 KRT17 POLA1 KTN1 PRPF6 SUCLG2 PGAM5 RAD50 LONP1 OPTN UMPS PLEC MAD2L1 AKAP7 | 4.95e-06 | 1005 | 179 | 18 | 19615732 |
| Pubmed | CUL1 MYH10 UACA DSP KTN1 SPTBN1 SMC6 PRPF6 PGAM5 ESYT2 LONP1 MDN1 TRIM28 PLEC DMD TMEM109 | 5.00e-06 | 809 | 179 | 16 | 32129710 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | MYH2 MYH10 FMR1 UACA DSP SPTAN1 SPTBN1 MYO18A PRPF6 PGAM5 RAD50 TRIM28 TAX1BP1 PLEC | 5.04e-06 | 626 | 179 | 14 | 33644029 |
| Pubmed | 5.55e-06 | 131 | 179 | 7 | 28634551 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH3 TBC1D30 DSP POLA1 KTN1 CEP290 LAMB3 QRICH2 PGAM5 SAMD9L MDN1 EXOC3L4 MCM3AP ANKRD18A DOP1B | 7.00e-06 | 736 | 179 | 15 | 29676528 |
| Pubmed | Skeletal muscle phenotypes initiated by ectopic MyoD in transgenic mouse heart. | 7.37e-06 | 8 | 179 | 3 | 1618148 | |
| Pubmed | 7.37e-06 | 8 | 179 | 3 | 16462940 | ||
| Pubmed | Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus. | 7.37e-06 | 8 | 179 | 3 | 17784784 | |
| Pubmed | 8.45e-06 | 92 | 179 | 6 | 37343697 | ||
| Pubmed | PDXDC1 DSP SPTAN1 KTN1 SPTBN1 TRIP11 ESYT2 SH3PXD2B GSDME CLCN7 RAB7A TMEM109 GOLGA4 | 8.67e-06 | 568 | 179 | 13 | 37774976 | |
| Pubmed | 8.80e-06 | 54 | 179 | 5 | 35474131 | ||
| Pubmed | MYH10 FMR1 UACA SPTAN1 SPTBN1 MYO18A PACSIN3 PRPF6 PGAM5 KRT80 TRIM28 MACF1 PLEC CCDC86 | 9.16e-06 | 660 | 179 | 14 | 32780723 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | CUL1 MYH10 FMR1 DSC1 UACA DSP SPTAN1 SPTBN1 MYO18A APOB PRPF6 PGAM5 OPTN TRIM28 TAX1BP1 PLEC CCDC86 | 9.17e-06 | 949 | 179 | 17 | 36574265 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCDC14 SNX4 MYH10 DSP CEP290 AIP TEX9 RAD50 ESYT2 LONP1 SH3PXD2B VPS52 PPP6C WASHC5 CEP250 PLEC | 9.67e-06 | 853 | 179 | 16 | 28718761 |
| Pubmed | NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. | 1.09e-05 | 27 | 179 | 4 | 23359859 | |
| Pubmed | 1.10e-05 | 9 | 179 | 3 | 12482924 | ||
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 1.25e-05 | 58 | 179 | 5 | 37117185 | |
| Pubmed | CCDC14 MYH3 RAP1GAP KRT17 ZNF177 SPTAN1 SPTBN1 VSIG4 LAMB3 PRPF6 NEB ANGPTL8 SPICE1 MDN1 TAX1BP1 PLEC FYB1 HYDIN GOLGB1 DOP1B | 1.25e-05 | 1293 | 179 | 20 | 15342556 | |
| Pubmed | Synemin acts as a regulator of signalling molecules during skeletal muscle hypertrophy. | 1.26e-05 | 28 | 179 | 4 | 25179606 | |
| Pubmed | SOX5 MYH10 SPTBN1 OPTN KMT2D CEP250 TRIM62 TAX1BP1 MCM3AP GMEB1 MACF1 PLEC GOLGB1 | 1.32e-05 | 591 | 179 | 13 | 15231748 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.33e-05 | 208 | 179 | 8 | 33230847 | |
| Pubmed | 1.41e-05 | 151 | 179 | 7 | 17043677 | ||
| Pubmed | Integrating genetic and network analysis to characterize genes related to mouse weight. | 1.46e-05 | 29 | 179 | 4 | 16934000 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CUL1 MYH10 EMC1 FMR1 DSC1 DSP POLA1 SPTAN1 KTN1 SPTBN1 SMC6 APOB PRPF6 PGAM5 RAD50 LONP1 MDN1 TRIM28 RAB7A CCDC86 GOLGA4 | 1.55e-05 | 1425 | 179 | 21 | 30948266 |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 1.57e-05 | 10 | 179 | 3 | 8950513 | |
| Pubmed | 1.57e-05 | 10 | 179 | 3 | 18240903 | ||
| Pubmed | MYH10 FMR1 UACA KTN1 MYO18A LAMB3 PRPF6 PGAM5 RAD50 LONP1 MACF1 PLEC CCDC86 | 1.57e-05 | 601 | 179 | 13 | 33658012 | |
| Pubmed | 1.88e-05 | 63 | 179 | 5 | 37052853 | ||
| Pubmed | PDXDC1 KRT17 DSP SPTAN1 KTN1 SPTBN1 MYO18A PRPF6 APOE LONP1 KMT2D MACF1 PLEC GOLGB1 | 2.09e-05 | 711 | 179 | 14 | 33022573 | |
| Pubmed | 2.13e-05 | 222 | 179 | 8 | 35941108 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CUL1 MYH2 MYH3 MYH8 UACA AIP RAD50 OPTN AKAP9 PPP6C TRIM28 CDK5RAP2 MYH15 PLEC MAD2L1 AKAP7 | 2.13e-05 | 910 | 179 | 16 | 36736316 |
| Pubmed | 2.15e-05 | 11 | 179 | 3 | 36411454 | ||
| Pubmed | 2.15e-05 | 11 | 179 | 3 | 37322017 | ||
| Pubmed | 2.15e-05 | 11 | 179 | 3 | 12802069 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EMC1 KRT17 DSP CEP290 PACSIN3 PRPF6 PGAM5 KRT80 RAD50 LONP1 MDN1 TRIM28 RAB7A MACF1 PLEC CCDC86 GOLGB1 | 2.42e-05 | 1024 | 179 | 17 | 24711643 |
| Pubmed | CUL1 MYH10 FMR1 UACA SPTAN1 KTN1 SPTBN1 PRPF6 APOE PGAM5 SPICE1 LONP1 AKAP9 PPP6C TRIM28 TAX1BP1 RAB7A TOLLIP MED12 | 2.57e-05 | 1247 | 179 | 19 | 27684187 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 15265687 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23761073 | ||
| Interaction | LATS1 interactions | CUL1 MYH2 MYH3 MYH8 KRT17 SPTAN1 SPTBN1 CEP290 LRRK2 NEB TRIP11 SPICE1 SYNE3 DNAH12 MDN1 AKAP9 XIRP2 CDK5RAP2 PLEC TMEM109 | 2.53e-09 | 440 | 179 | 20 | int:LATS1 |
| Interaction | RHOD interactions | PDXDC1 CUL1 EMC1 SPTAN1 KTN1 SPTBN1 MYO18A PACSIN3 MTMR1 GOLGA8R ESYT2 LONP1 MDN1 CLCN7 RAB7A MACF1 TMEM109 VAMP8 GOLGA4 GOLGB1 | 1.94e-07 | 572 | 179 | 20 | int:RHOD |
| Interaction | KRT19 interactions | CCDC14 KRT72 KRT17 SYNM DSP KTN1 CEP290 TEX9 KRT80 SPICE1 AKAP9 CDK5RAP2 PLEC DMD | 2.40e-07 | 282 | 179 | 14 | int:KRT19 |
| Interaction | KIF20A interactions | MYH10 FMR1 UACA DSP SPTAN1 KTN1 SPTBN1 MYO18A PACSIN3 TRIM54 APOB PRPF6 TRIP11 PGAM5 NSD3 LONP1 SAMD9L FER1L4 CDK5RAP2 MACF1 ANKRD18A ABCG2 GALNT6 PLEC CCDC86 MAD2L1 SMG6 | 6.54e-07 | 1052 | 179 | 27 | int:KIF20A |
| Interaction | RAC3 interactions | PDXDC1 EMC1 UACA PLEKHG4 SPTAN1 KTN1 SPTBN1 MYO18A PACSIN3 MTMR1 TRIP11 ESYT2 LONP1 CLCN7 GLUD2 RAB7A MACF1 VAMP8 GOLGA4 GOLGB1 | 6.74e-07 | 619 | 179 | 20 | int:RAC3 |
| Interaction | IFITM1 interactions | PDXDC1 MYH10 FMR1 NCAM1 APOB TRIP11 LONP1 CLCN7 WASHC5 RAB7A TOLLIP VAMP8 SNX12 GOLGA4 GOLGB1 | 6.93e-07 | 355 | 179 | 15 | int:IFITM1 |
| Interaction | PCNT interactions | CCDC14 FMR1 SPTAN1 SPTBN1 CEP290 TRIP11 SPICE1 SYNE3 AKAP9 CDK5RAP2 MACF1 PLEC | 1.73e-06 | 241 | 179 | 12 | int:PCNT |
| Interaction | YWHAZ interactions | CUL1 TRAPPC11 MYH10 RAP1GAP SH3RF1 DSC1 KRT17 UACA COL6A6 RASGRF1 CORO2A SPTAN1 SPTBN1 KSR2 LRRK2 MYO18A MTMR1 DZIP1 APOE NEB OPTN MCTP1 AKAP9 CEP112 TAX1BP1 CDK5RAP2 MACF1 PLEC CDC25C RUNDC1 | 1.80e-06 | 1319 | 179 | 30 | int:YWHAZ |
| Interaction | CDC42 interactions | PDXDC1 CUL1 MYH10 EMC1 FMR1 PLEKHG4 DSP SPTAN1 KTN1 SPTBN1 KSR2 LRRK2 MYO18A PACSIN3 MTMR1 GOLGA8R TRIP11 ESYT2 LONP1 VPS52 MDN1 CLCN7 TRIM28 MCM3AP GLUD2 RAB7A TMEM109 VAMP8 COG5 GOLGB1 | 1.92e-06 | 1323 | 179 | 30 | int:CDC42 |
| Interaction | MYH6 interactions | 1.92e-06 | 94 | 179 | 8 | int:MYH6 | |
| Interaction | KRT8 interactions | CCDC14 KRT72 TRAPPC11 KRT17 UACA SYNM DSP TRIM54 TRIP11 SPICE1 ESYT2 AKAP9 PPP6C CDK5RAP2 PLEC DMD | 2.15e-06 | 441 | 179 | 16 | int:KRT8 |
| Interaction | CFTR interactions | PDXDC1 KRT72 CUL1 MYH2 MYH3 MYH8 SNX4 MYH10 RAP1GAP DSC1 KRT17 DSP MYH7B SPTAN1 SPTBN1 MYO18A LAMB3 PRPF6 SUCLG2 PGAM5 RYR3 KRT80 ESYT2 OPTN GSDME MDN1 TRIM28 TAX1BP1 MACF1 PLEC DMD MED12 | 2.29e-06 | 1480 | 179 | 32 | int:CFTR |
| Interaction | RHOH interactions | EMC1 UACA SPTAN1 KTN1 SPTBN1 MYO18A PACSIN3 MTMR1 TRIP11 ESYT2 LONP1 MDN1 CLCN7 CEP250 RAB7A GOLGA4 GOLGB1 | 3.38e-06 | 512 | 179 | 17 | int:RHOH |
| Interaction | ZUP1 interactions | 3.65e-06 | 174 | 179 | 10 | int:ZUP1 | |
| Interaction | NDC80 interactions | CCDC14 UACA CEP290 TEX9 PGAM5 SPICE1 RAD50 VPS52 AKAP9 CEP250 MAD1L1 CDK5RAP2 MAD2L1 | 4.57e-06 | 312 | 179 | 13 | int:NDC80 |
| Interaction | YWHAH interactions | TRAPPC11 RAP1GAP EMC1 SH3RF1 UACA DSP SPTAN1 SPTBN1 CEP290 KSR2 LRRK2 PRPF6 DZIP1 TRIP11 NSD3 ESYT2 SH3PXD2B OPTN AKAP9 CEP112 MAD1L1 MACF1 PLEC CDC25C GOLGA4 DOP1B | 5.03e-06 | 1102 | 179 | 26 | int:YWHAH |
| Interaction | CEP135 interactions | CCDC14 SYNM CEP290 TEX9 PGAM5 SPICE1 AKAP9 CEP112 CEP250 GLUD2 CDK5RAP2 GOLGB1 | 6.03e-06 | 272 | 179 | 12 | int:CEP135 |
| Interaction | DNAJC5 interactions | UACA SPTAN1 SPTBN1 MYO18A MTMR1 DZIP1 KHDC4 ESYT2 CLCN7 RAB7A MACF1 VAMP8 GOLGA4 GOLGB1 | 7.55e-06 | 378 | 179 | 14 | int:DNAJC5 |
| Interaction | RAC1 interactions | EMC1 FMR1 SH3RF1 RASGRF1 PLEKHG4 SPTAN1 KTN1 SPTBN1 LRRK2 MYO18A PACSIN3 MTMR1 GOLGA8R ESYT2 LONP1 OPTN VPS52 MDN1 CLCN7 MCM3AP RAB7A TOLLIP MACF1 TMEM109 COG5 | 8.25e-06 | 1063 | 179 | 25 | int:RAC1 |
| Interaction | RAC2 interactions | PDXDC1 CUL1 EMC1 PLEKHG4 SPTAN1 KTN1 SPTBN1 MYO18A MTMR1 TRIP11 ESYT2 LONP1 CLCN7 GLUD2 RAB7A MACF1 TMEM109 GOLGA4 GOLGB1 | 9.35e-06 | 674 | 179 | 19 | int:RAC2 |
| Interaction | DST interactions | PDXDC1 KRT17 SPTAN1 KTN1 CEP290 MYO18A CLIP4 OPTN SYNE3 CEP250 RAB7A PLEC | 1.04e-05 | 287 | 179 | 12 | int:DST |
| Interaction | RAB2A interactions | PDXDC1 TRAPPC11 EMC1 SPTBN1 CEP290 MYO18A NCAM1 SUCLG2 TRIP11 SPICE1 ESYT2 LONP1 CLCN7 RAB7A TMEM109 GOLGA4 GOLGB1 | 1.29e-05 | 567 | 179 | 17 | int:RAB2A |
| Interaction | RAB7A interactions | PDXDC1 SNX4 EMC1 SZT2 KTN1 LRRK2 APOE TRIP11 ESYT2 OPTN CLCN7 WASHC5 TRIM28 TAX1BP1 TENM1 RAB7A ABCG2 VAMP8 GOLGA4 GOLGB1 MAD2L1 DOP1B | 1.32e-05 | 886 | 179 | 22 | int:RAB7A |
| Interaction | USP7 interactions | CUL1 MYH3 TRAF5 FMR1 KRT17 DSP POLA1 SPTAN1 SPTBN1 LRRK2 TRIM54 UPRT NEB RAD50 KMT2D SAMD9L MDN1 PPP6C CEP112 CEP250 KANK4 MACF1 UMPS MAFB PLEC DMD SNX12 GOLGB1 | 1.39e-05 | 1313 | 179 | 28 | int:USP7 |
| Interaction | TPM1 interactions | MYH2 MYH8 MYH7B SPTBN1 LRRK2 MYO18A APOE NEB CLIP4 MAD1L1 TOLLIP | 2.43e-05 | 263 | 179 | 11 | int:TPM1 |
| Interaction | CDC5L interactions | CUL1 FMR1 DSP SPTAN1 SPTBN1 PRPF6 KHDC4 RAD50 VPS52 GSDME PPP4C MDN1 AKAP9 MAD1L1 MED12L MACF1 UMPS MAFB PLEC SNX12 GOLGB1 | 2.47e-05 | 855 | 179 | 21 | int:CDC5L |
| Interaction | FBXO22 interactions | CUL1 COL6A6 KTN1 SPTBN1 PRPF6 APOE NEB RYR3 DNAH12 PPP4C MDN1 XIRP2 TSEN34 TMEM109 HYDIN MED12 | 2.70e-05 | 540 | 179 | 16 | int:FBXO22 |
| Interaction | BTF3 interactions | MYH2 MYH10 FMR1 UACA DSP POLA1 SPTAN1 SPTBN1 SMC6 MYO18A PRPF6 PGAM5 SPICE1 RAD50 LONP1 TRIM28 TAX1BP1 PLEC GNG10 MAD2L1 | 2.99e-05 | 799 | 179 | 20 | int:BTF3 |
| Interaction | CCDC18 interactions | 3.13e-05 | 68 | 179 | 6 | int:CCDC18 | |
| Interaction | CEP63 interactions | 3.27e-05 | 179 | 179 | 9 | int:CEP63 | |
| Interaction | RND3 interactions | PDXDC1 EMC1 KRT17 DSP SPTAN1 KTN1 SPTBN1 MYO18A MTMR1 LONP1 RAB7A | 3.43e-05 | 273 | 179 | 11 | int:RND3 |
| Interaction | BCAP31 interactions | MYH2 MYH3 MYH8 MYH10 EMC1 MYH7B KTN1 CEP290 APOB ESYT2 SYNE3 PPP6C CLCN7 RAB7A MYH15 TMEM109 | 3.67e-05 | 554 | 179 | 16 | int:BCAP31 |
| Interaction | STK25 interactions | 3.99e-05 | 104 | 179 | 7 | int:STK25 | |
| Interaction | RND2 interactions | PDXDC1 EMC1 SPTAN1 KTN1 SPTBN1 MTMR1 TRIP11 ESYT2 LONP1 MDN1 CLCN7 RAB7A GOLGA4 GOLGB1 | 4.07e-05 | 440 | 179 | 14 | int:RND2 |
| Interaction | YWHAG interactions | TRAPPC11 MYH10 RAP1GAP SH3RF1 UACA DSP SPTAN1 SPTBN1 KSR2 LRRK2 DZIP1 TRIP11 PGAM5 SPICE1 ESYT2 OPTN TTBK1 MDN1 AKAP9 CEP112 CEP250 MAD1L1 IQSEC1 MACF1 MAFB CDC25C | 4.34e-05 | 1248 | 179 | 26 | int:YWHAG |
| Interaction | CALM1 interactions | CCDC14 CUL1 EMC1 DNAAF4 CEP290 LRRK2 MYO18A CAMTA2 NEB RGS10 OPTN AKAP9 MCM3AP CDK5RAP2 CAMKMT FBXL2 ZBED1 | 4.51e-05 | 626 | 179 | 17 | int:CALM1 |
| Interaction | APC interactions | MYH10 FMR1 KRT17 SPTBN1 NEB SYNE3 CEP250 TAX1BP1 MCM3AP MAD1L1 MACF1 COG5 MAD2L1 | 4.69e-05 | 389 | 179 | 13 | int:APC |
| Interaction | STYXL1 interactions | 4.79e-05 | 45 | 179 | 5 | int:STYXL1 | |
| Interaction | DPP4 interactions | PDXDC1 MYH10 EMC1 FMR1 SPTAN1 KTN1 SPTBN1 MYO18A APOB TRIP11 ESYT2 LONP1 CLCN7 GOLGB1 | 5.57e-05 | 453 | 179 | 14 | int:DPP4 |
| Interaction | USP2 interactions | PLEKHG4 TRIM54 TRIM34 CCDC88B DYDC1 LONP1 OPTN VPS52 TAX1BP1 ZBED1 | 5.71e-05 | 239 | 179 | 10 | int:USP2 |
| Interaction | LAMP1 interactions | PDXDC1 TRAPPC11 EMC1 SZT2 SPTAN1 KTN1 SPTBN1 MYO18A MTMR1 AIP TRIP11 ESYT2 CLCN7 RAB7A MACF1 VAMP8 GOLGB1 | 6.39e-05 | 644 | 179 | 17 | int:LAMP1 |
| Interaction | RND1 interactions | 7.27e-05 | 246 | 179 | 10 | int:RND1 | |
| Interaction | CLEC4E interactions | MYH10 EMC1 FMR1 SPTAN1 KTN1 MYO18A ESYT2 LONP1 CLCN7 TAX1BP1 RAB7A GOLGB1 | 7.84e-05 | 353 | 179 | 12 | int:CLEC4E |
| Interaction | CCDC182 interactions | 7.85e-05 | 2 | 179 | 2 | int:CCDC182 | |
| Interaction | ATOH1 interactions | 7.87e-05 | 80 | 179 | 6 | int:ATOH1 | |
| Interaction | CCT8L2 interactions | 8.22e-05 | 157 | 179 | 8 | int:CCT8L2 | |
| Interaction | CSK interactions | TRAF5 PLEKHG4 KTN1 CEP290 LRRK2 LAMB3 GRIA4 UPRT TRIP11 ELMO1 RAD50 SAMD9L SYNE3 ANGPTL3 KANK4 ABCG2 FBXL2 HYDIN GOLGA4 AKAP7 | 8.42e-05 | 861 | 179 | 20 | int:CSK |
| Interaction | DES interactions | 8.59e-05 | 158 | 179 | 8 | int:DES | |
| Interaction | STIP1 interactions | PDXDC1 CCDC14 CUL1 MYH10 FMR1 POLA1 SPTAN1 SPTBN1 LRRK2 PRPF6 AIP NEB PGAM5 RAD50 ESYT2 LONP1 MDN1 TRIM28 RAB7A UMPS PLEC CDC25C | 8.85e-05 | 1006 | 179 | 22 | int:STIP1 |
| Interaction | UCHL1 interactions | 9.18e-05 | 253 | 179 | 10 | int:UCHL1 | |
| Interaction | PRNP interactions | CCDC14 CUL1 SNX4 SH3RF1 POLA1 CEP290 PACSIN3 MTMR1 NCAM1 APOE NSD3 CLIP4 ESYT2 LONP1 SYNE3 MDN1 AKAP9 CCDC149 EXOC3L4 TOLLIP CDK5RAP2 MACF1 UMPS DMD | 9.53e-05 | 1158 | 179 | 24 | int:PRNP |
| Interaction | KCNA3 interactions | SH3RF1 SZT2 DSP MYH7B KTN1 SPTBN1 LRRK2 MYO18A MTMR1 SPICE1 RAD50 ESYT2 TRIM28 CEP112 RAB7A CDK5RAP2 MACF1 MED12 GOLGA4 GOLGB1 | 9.85e-05 | 871 | 179 | 20 | int:KCNA3 |
| Interaction | YWHAB interactions | TRAPPC11 RAP1GAP EMC1 SH3RF1 UACA RASGRF1 SPTAN1 SPTBN1 KSR2 LRRK2 NCAM1 PRPF6 DZIP1 NEB TRIP11 RAD50 ESYT2 OPTN AKAP9 CEP112 MACF1 CDC25C | 9.93e-05 | 1014 | 179 | 22 | int:YWHAB |
| Interaction | CLEC4D interactions | MYH10 EMC1 FMR1 SPTAN1 KTN1 MYO18A TRIP11 LONP1 GOLGB1 DOP1B | 1.19e-04 | 261 | 179 | 10 | int:CLEC4D |
| Interaction | TFRC interactions | PDXDC1 EMC1 SPTAN1 KTN1 SPTBN1 MYO18A APOE OPTN SYNE3 TRIM28 RAB7A TOLLIP MYH15 GOLGB1 | 1.25e-04 | 489 | 179 | 14 | int:TFRC |
| Interaction | CAPZA2 interactions | MYH10 CORO2A SPTAN1 KTN1 SPTBN1 LRRK2 MYO18A PACSIN3 WASHC5 TRIM28 CDK5RAP2 MACF1 PLEC | 1.28e-04 | 430 | 179 | 13 | int:CAPZA2 |
| Interaction | SNAPIN interactions | 1.37e-04 | 169 | 179 | 8 | int:SNAPIN | |
| Interaction | PCM1 interactions | CCDC14 FMR1 DSP CEP290 PRPF6 TEX9 SPICE1 AKAP9 CEP112 CEP250 TAX1BP1 CDK5RAP2 COG5 | 1.41e-04 | 434 | 179 | 13 | int:PCM1 |
| Interaction | BORCS6 interactions | 1.43e-04 | 170 | 179 | 8 | int:BORCS6 | |
| Interaction | ZNF598 interactions | MYH10 FMR1 DSC1 KRT17 DSP SPTAN1 KTN1 SPTBN1 NCAM1 PGAM5 SYNE3 TRIM28 RAB7A | 1.44e-04 | 435 | 179 | 13 | int:ZNF598 |
| Interaction | SYNE2 interactions | 1.54e-04 | 219 | 179 | 9 | int:SYNE2 | |
| Interaction | RHOA interactions | PDXDC1 EMC1 RASGRF1 PLEKHG4 SPTAN1 KTN1 SPTBN1 LRRK2 MYO18A PACSIN3 MTMR1 TRIP11 ESYT2 LONP1 OPTN VPS52 MDN1 PPP6C CLCN7 RAB7A MACF1 TMEM109 GOLGA4 GOLGB1 | 1.62e-04 | 1199 | 179 | 24 | int:RHOA |
| Interaction | TRIM37 interactions | CCDC14 MYH2 TRAF5 MYH10 SYNM DSP SPTAN1 SPTBN1 MYO18A SPICE1 KMT2D SYNE3 CEP250 MCM3AP CDK5RAP2 PLEC | 1.64e-04 | 630 | 179 | 16 | int:TRIM37 |
| Interaction | VCP interactions | PDXDC1 CUL1 CYP2C9 EMC1 KRT17 DSP SPTAN1 SPTBN1 TRIM54 APOB AIP APOE NEB SUCLG2 RYR3 RAD50 LONP1 OPTN MDN1 PPP6C TRIM28 TAX1BP1 RAB7A ABCG2 PLEC COG5 FBXL2 | 1.69e-04 | 1435 | 179 | 27 | int:VCP |
| Interaction | NRAS interactions | PDXDC1 UACA CORO2A SPTAN1 KTN1 SPTBN1 MTMR1 NCAM1 TRIP11 ESYT2 CLCN7 TRIM28 MACF1 TMEM109 VAMP8 FYB1 GOLGB1 | 1.71e-04 | 699 | 179 | 17 | int:NRAS |
| Interaction | STX6 interactions | PDXDC1 SPTAN1 KTN1 SPTBN1 TRIP11 ESYT2 VPS52 CLCN7 RAB7A MACF1 VAMP8 GOLGA4 GOLGB1 | 1.92e-04 | 448 | 179 | 13 | int:STX6 |
| Interaction | IFITM3 interactions | PDXDC1 TRAPPC11 FMR1 SPTAN1 NCAM1 TRIP11 LONP1 CLCN7 WASHC5 RAB7A TMEM109 SNX12 GOLGA4 GOLGB1 | 2.05e-04 | 513 | 179 | 14 | int:IFITM3 |
| Interaction | CCHCR1 interactions | 2.15e-04 | 229 | 179 | 9 | int:CCHCR1 | |
| Interaction | HAUS1 interactions | 2.37e-04 | 183 | 179 | 8 | int:HAUS1 | |
| Interaction | NPHP4 interactions | 2.69e-04 | 236 | 179 | 9 | int:NPHP4 | |
| Interaction | PPP1R18 interactions | 2.70e-04 | 141 | 179 | 7 | int:PPP1R18 | |
| Interaction | DUSP16 interactions | 2.78e-04 | 237 | 179 | 9 | int:DUSP16 | |
| Interaction | RNF38 interactions | 3.00e-04 | 102 | 179 | 6 | int:RNF38 | |
| Interaction | VIM interactions | KRT72 CUL1 SNX4 KRT17 UACA SYNM DSP SPTAN1 TNFRSF14 LRRK2 GRIA4 PRPF6 TEX9 NEB TRIM28 TRIM62 PLEC GOLGA4 | 3.03e-04 | 804 | 179 | 18 | int:VIM |
| Interaction | CEP43 interactions | 3.05e-04 | 190 | 179 | 8 | int:CEP43 | |
| Interaction | CDK5RAP2 interactions | 3.05e-04 | 190 | 179 | 8 | int:CDK5RAP2 | |
| Interaction | TEX9 interactions | 3.16e-04 | 37 | 179 | 4 | int:TEX9 | |
| Interaction | GORASP1 interactions | 3.17e-04 | 103 | 179 | 6 | int:GORASP1 | |
| Interaction | RHOF interactions | PDXDC1 EMC1 UACA SPTAN1 SPTBN1 PACSIN3 MTMR1 ESYT2 LONP1 VPS52 MDN1 CLCN7 RAB7A MACF1 VAMP8 GOLGB1 | 3.44e-04 | 673 | 179 | 16 | int:RHOF |
| Interaction | LUZP1 interactions | 3.51e-04 | 194 | 179 | 8 | int:LUZP1 | |
| Interaction | SIRT7 interactions | MYH10 FMR1 DSP POLA1 SPTAN1 SPTBN1 PRPF6 PGAM5 RAD50 LONP1 MDN1 MCM3AP HELZ2 MACF1 PLEC CCDC86 MED12 | 3.54e-04 | 744 | 179 | 17 | int:SIRT7 |
| Interaction | AMPD1 interactions | 3.54e-04 | 16 | 179 | 3 | int:AMPD1 | |
| Interaction | ECT2 interactions | MYH10 FMR1 CORO2A DSP SPTAN1 SPTBN1 MYO18A PACSIN3 PRPF6 SUCLG2 PGAM5 ESYT2 TRIM28 EXOC3L4 MACF1 ABCG2 PLEC DNAH9 DOP1B | 3.56e-04 | 887 | 179 | 19 | int:ECT2 |
| Interaction | SCARB2 interactions | 3.63e-04 | 195 | 179 | 8 | int:SCARB2 | |
| Interaction | CEP72 interactions | 3.89e-04 | 107 | 179 | 6 | int:CEP72 | |
| Interaction | MYH9 interactions | CUL1 MYH10 UACA CORO2A SPTAN1 SPTBN1 LRRK2 MYO18A PACSIN3 GRIA4 APOB OPTN GSDME CEP250 MACF1 PLEC GOLGA4 | 4.13e-04 | 754 | 179 | 17 | int:MYH9 |
| Interaction | LAMP3 interactions | PDXDC1 KTN1 SPTBN1 TRIP11 MDN1 CLCN7 RAB7A TMEM109 VAMP8 SNX12 GOLGA4 GOLGB1 DOP1B | 4.19e-04 | 486 | 179 | 13 | int:LAMP3 |
| Interaction | GAPDH interactions | CUL1 EMC1 FMR1 KRT17 DSP MYH7B CEP290 QRICH2 SLC4A3 SAMD9L DNAH12 PPP6C TRIM28 MACF1 GOLGA4 AKAP7 | 4.24e-04 | 686 | 179 | 16 | int:GAPDH |
| Interaction | MYO19 interactions | 4.35e-04 | 252 | 179 | 9 | int:MYO19 | |
| Interaction | DLST interactions | FMR1 DSP MYO18A PRPF6 RAD50 LONP1 TTBK1 TRIM28 TAX1BP1 RAB7A UMPS PLEC CCDC86 | 4.53e-04 | 490 | 179 | 13 | int:DLST |
| Interaction | AURKB interactions | CUL1 MYH10 FMR1 DSP LRRK2 VSIG4 MTMR1 AIP RAD50 LONP1 PPP6C TRIM28 TAX1BP1 CDK5RAP2 MACF1 PLEC FBXL2 | 4.58e-04 | 761 | 179 | 17 | int:AURKB |
| Interaction | LMO1 interactions | 4.60e-04 | 154 | 179 | 7 | int:LMO1 | |
| Interaction | METTL14 interactions | KRT72 MYH10 DSC1 DSP SPTAN1 KTN1 SPTBN1 RYR3 KRT80 TRIM28 GLUD2 PLEC TMEM109 SMG6 | 4.78e-04 | 558 | 179 | 14 | int:METTL14 |
| Interaction | TRIM6 interactions | 4.82e-04 | 73 | 179 | 5 | int:TRIM6 | |
| Interaction | RHOG interactions | PDXDC1 EMC1 KRT17 UACA SPTAN1 KTN1 SPTBN1 MTMR1 TRIP11 ELMO1 ESYT2 LONP1 CLCN7 RAB7A MACF1 TMEM109 VAMP8 GOLGA4 GOLGB1 | 4.87e-04 | 910 | 179 | 19 | int:RHOG |
| Interaction | TEDC2 interactions | 5.22e-04 | 206 | 179 | 8 | int:TEDC2 | |
| Interaction | HERC2 interactions | MYH10 FMR1 KTN1 SPTBN1 CEP290 LRRK2 KRT80 KMT2D AKAP9 CEP250 MACF1 PLEC CDC25C | 5.78e-04 | 503 | 179 | 13 | int:HERC2 |
| Interaction | TOP3B interactions | MYH10 FMR1 SH3RF1 SZT2 SPTAN1 KTN1 KSR2 RDH10 LAMB3 APOB NSD3 LONP1 SH3PXD2B KMT2D SYNE3 MDN1 CLCN7 TRIM28 MCM3AP MAD1L1 HELZ2 AP1G2 PLEC VAMP8 MED12 SMG6 | 5.81e-04 | 1470 | 179 | 26 | int:TOP3B |
| Interaction | DDX39B interactions | MYH10 DSC1 KRT17 CORO2A DSP SPTAN1 SPTBN1 MYO18A PRPF6 KRT80 GVINP1 TRIM28 IQSEC1 PLEC | 5.90e-04 | 570 | 179 | 14 | int:DDX39B |
| Interaction | ZNF227 interactions | 6.01e-04 | 19 | 179 | 3 | int:ZNF227 | |
| GeneFamily | Myosin heavy chains | 2.49e-10 | 15 | 113 | 6 | 1098 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.30e-05 | 8 | 113 | 3 | 939 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 7.72e-04 | 29 | 113 | 3 | 396 | |
| GeneFamily | EF-hand domain containing|Spectrins | 7.97e-04 | 7 | 113 | 2 | 1113 | |
| GeneFamily | Fibrinogen C domain containing|Angiopoietin like | 1.06e-03 | 8 | 113 | 2 | 905 | |
| GeneFamily | Ring finger proteins | 1.71e-03 | 275 | 113 | 7 | 58 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.89e-03 | 13 | 113 | 2 | 693 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 2.98e-03 | 95 | 113 | 4 | 59 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYH10 KTN1 CEP290 SMC6 DZIP1 TRIP11 RAD50 KIAA0319 OPTN WASHC5 CEP112 SCOC TAX1BP1 CDK5RAP2 FYB1 GOLGA4 GOLGB1 | 2.46e-06 | 656 | 177 | 17 | M18979 |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 3.78e-06 | 179 | 177 | 9 | M39308 | |
| Coexpression | GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN | 8.92e-06 | 199 | 177 | 9 | M9701 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP | 9.28e-06 | 200 | 177 | 9 | M6004 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 1.80e-05 | 166 | 177 | 8 | M39026 | |
| Coexpression | DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS | 2.13e-05 | 170 | 177 | 8 | M40176 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | CUL1 SNX4 FMR1 KTN1 GSDME MCM3AP MACF1 UMPS COG5 GOLGA8A GOLGA4 MAD2L1 DOP1B | 2.55e-05 | 481 | 177 | 13 | M3898 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | UACA DSP SPTBN1 MYO18A KRT80 CLIP4 OPTN TAX1BP1 HELZ2 RAB7A ABCG2 VAMP8 | 4.12e-05 | 433 | 177 | 12 | M2240 |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP | 4.88e-05 | 96 | 177 | 6 | M5549 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 5.87e-05 | 196 | 177 | 8 | M5381 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | 6.09e-05 | 197 | 177 | 8 | M6512 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP | 6.53e-05 | 199 | 177 | 8 | M8396 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 6.53e-05 | 199 | 177 | 8 | M6638 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 6.77e-05 | 200 | 177 | 8 | M9889 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 6.77e-05 | 200 | 177 | 8 | M5063 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN | 6.77e-05 | 200 | 177 | 8 | M6560 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | UACA KTN1 CEP290 TEX9 TRIP11 RAD50 MAB21L3 AKAP9 ANKRD18A GOLGA4 GOLGB1 | 5.57e-10 | 199 | 179 | 11 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDXDC1 CYP2C9 DSP RDH10 SAMD12 KHDC4 TUFT1 MACF1 GOLGA8A GOLGB1 | 3.11e-09 | 179 | 179 | 10 | 6e965e424eebef50f0202cff75f458be395cfca1 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-09 | 184 | 179 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-09 | 184 | 179 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-09 | 184 | 179 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | KRT17 KTN1 CEP290 TRIP11 RAD50 MAB21L3 AKAP9 TAX1BP1 GOLGA4 GOLGB1 | 8.61e-09 | 199 | 179 | 10 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | KTN1 CEP290 SMC6 TRIP11 NSD3 RAD50 MAB21L3 AKAP9 GOLGA4 GOLGB1 | 8.61e-09 | 199 | 179 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | KTN1 SMC6 TRIP11 NSD3 RAD50 MAB21L3 AKAP9 ANKRD18A GOLGA4 GOLGB1 | 8.61e-09 | 199 | 179 | 10 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | KTN1 CEP290 SMC6 TRIP11 NSD3 RAD50 MAB21L3 AKAP9 GOLGA4 GOLGB1 | 8.61e-09 | 199 | 179 | 10 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-07 | 197 | 179 | 9 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | UACA CEP290 RAD50 AKAP9 CDK5RAP2 ANKRD18A GOLGA8A GOLGB1 SMG6 | 1.10e-07 | 197 | 179 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | CUL1 CEP290 TRIP11 RAD50 MAB21L3 AKAP9 TAX1BP1 GOLGA4 GOLGB1 | 1.15e-07 | 198 | 179 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-07 | 176 | 179 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 189 | 179 | 8 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 189 | 179 | 8 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-06 | 190 | 179 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-CR-CR_Lhx5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.07e-06 | 83 | 179 | 6 | 75b27d91a4473286f4b40027e96ac5246f5abe5b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-CR|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.07e-06 | 83 | 179 | 6 | 1ab68323518adc7fd0a459b41fad12d60f97eb5c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-06 | 132 | 179 | 7 | 66ec5a06eece27c0aafb548f51db9fee595e71bc | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.49e-06 | 199 | 179 | 8 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.49e-06 | 199 | 179 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.49e-06 | 199 | 179 | 8 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.49e-06 | 199 | 179 | 8 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.54e-06 | 200 | 179 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.43e-06 | 163 | 179 | 7 | b0aa4a620bd58011225b42ea6dda04e3101ba342 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-06 | 180 | 179 | 7 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-06 | 180 | 179 | 7 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 182 | 179 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.45e-06 | 183 | 179 | 7 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.80e-06 | 184 | 179 | 7 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 186 | 179 | 7 | e52cf44989c57c433bf82e9fa13b4643e88f3577 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 186 | 179 | 7 | 4c0b59d845b79323e7a3287e7c4d249f5f322556 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-05 | 190 | 179 | 7 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.21e-05 | 190 | 179 | 7 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.25e-05 | 191 | 179 | 7 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.25e-05 | 191 | 179 | 7 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 191 | 179 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-05 | 191 | 179 | 7 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-05 | 191 | 179 | 7 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.29e-05 | 192 | 179 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.34e-05 | 193 | 179 | 7 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 194 | 179 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 194 | 179 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 194 | 179 | 7 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.43e-05 | 195 | 179 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.43e-05 | 195 | 179 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-05 | 195 | 179 | 7 | b6bf75669f267ecdc96818c7022db852e37a9fe1 | |
| ToppCell | 11.5-Distal-Epithelial-Bud_tip_progenitor|Distal / Age, Tissue, Lineage and Cell class | 1.48e-05 | 196 | 179 | 7 | 42eae265e2f2082983d8c2607c7f6a53a526d124 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 196 | 179 | 7 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 196 | 179 | 7 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 196 | 179 | 7 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.52e-05 | 197 | 179 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 197 | 179 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | COVID-19_Severe-Neu_4|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 1.58e-05 | 198 | 179 | 7 | bfdddddef9f3f0eb6af013873dec4e06b7c78c58 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 198 | 179 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.63e-05 | 199 | 179 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.63e-05 | 199 | 179 | 7 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.68e-05 | 200 | 179 | 7 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.68e-05 | 200 | 179 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.68e-05 | 200 | 179 | 7 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.68e-05 | 200 | 179 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.68e-05 | 200 | 179 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.68e-05 | 200 | 179 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.68e-05 | 200 | 179 | 7 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.68e-05 | 200 | 179 | 7 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.68e-05 | 200 | 179 | 7 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | 1.68e-05 | 200 | 179 | 7 | a549aa08aeefe905653266dae3936094ff55f8e4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.68e-05 | 200 | 179 | 7 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Gpr139|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.72e-05 | 134 | 179 | 6 | 917b8951dd4c870b6b92f2e73e02dac884330c30 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.03e-05 | 138 | 179 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.90e-05 | 155 | 179 | 6 | 93f21b09f6f7755991d67886361b1c42a50fbbfc | |
| ToppCell | Myeloid-A_(Macrophage-Dendritic)|World / shred on cell class and cell subclass (v4) | 4.04e-05 | 156 | 179 | 6 | 08d5f7fe098b6f2caeeddcc5ed1e34d6a59e697b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 160 | 179 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 160 | 179 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.82e-05 | 161 | 179 | 6 | da9eecf919866a9c579d7a707a996cf335213134 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-05 | 161 | 179 | 6 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.82e-05 | 161 | 179 | 6 | d431625c32f59a6b552191f3adc5198bd16ad5cf | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.99e-05 | 162 | 179 | 6 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 164 | 179 | 6 | d5bb57c321f2973836efc8990449494cc1fb87c7 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 164 | 179 | 6 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 164 | 179 | 6 | 758e85e2f5e7236b345e16c78344d5e0bf17d8dc | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.52e-05 | 165 | 179 | 6 | 47e716ce8dc283d406352c1909e09362fcb9e3a3 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.52e-05 | 165 | 179 | 6 | fe2135fdacf3807eb4b5ea5e790febfb8cd54335 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 5.71e-05 | 166 | 179 | 6 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.71e-05 | 166 | 179 | 6 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.31e-05 | 169 | 179 | 6 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.31e-05 | 169 | 179 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 169 | 179 | 6 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 169 | 179 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.73e-05 | 171 | 179 | 6 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Megakaryocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.73e-05 | 171 | 179 | 6 | 9dda25df493766723335851b3c3d89735b6e8051 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 174 | 179 | 6 | 7c52b5d8f1e65e5208c952be341fa155ed0e6e76 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 174 | 179 | 6 | 2fbdb62e269acf4447b171700a615e878dde7f9f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 176 | 179 | 6 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 177 | 179 | 6 | 43883b65b1e03043a24fc40c84c50bac81960c12 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 177 | 179 | 6 | 9de6a82b7fb72d20361947f7ac95bb1fa73fc2ff | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.15e-05 | 177 | 179 | 6 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 177 | 179 | 6 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.15e-05 | 177 | 179 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.15e-05 | 177 | 179 | 6 | 3a150dcaefa342d49968b42c7cdb1fbb633adcd0 | |
| Drug | plakin | 1.52e-08 | 82 | 177 | 9 | CID000018752 | |
| Drug | purealin | 3.28e-07 | 58 | 177 | 7 | CID006419303 | |
| Drug | PB-3 | 1.90e-06 | 48 | 177 | 6 | CID005289109 | |
| Drug | candesartan cilexetil | 2.07e-06 | 145 | 177 | 9 | CID000002540 | |
| Drug | formycin triphosphate | 2.73e-06 | 51 | 177 | 6 | CID000122274 | |
| Drug | B0683 | 3.78e-06 | 117 | 177 | 8 | CID006398969 | |
| Drug | oxovanadium | 4.56e-06 | 120 | 177 | 8 | CID000024411 | |
| Drug | dimyristoylphosphatidylcholine | 1.05e-05 | 64 | 177 | 6 | CID000026197 | |
| Drug | N-ethylmaleimide | MYH2 MYH3 MYH8 MYH10 MYH7B POLA1 SPTAN1 SPTBN1 MYO18A GRIA4 SLC4A1 VAMP8 COG5 GOLGB1 SMG6 | 1.17e-05 | 511 | 177 | 15 | CID000004362 |
| Drug | clenbuterol | 1.58e-05 | 142 | 177 | 8 | CID000002783 | |
| Drug | fast white | 1.81e-05 | 42 | 177 | 5 | CID000024008 | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | RAP1GAP EMC1 TBC1D30 SPTAN1 SPTBN1 CEP250 MCM3AP MYH15 AKAP7 | 2.11e-05 | 193 | 177 | 9 | 4488_DN |
| Drug | MgCl2 | MYH2 MYH3 MYH8 MYH10 PLEKHG4 MYH7B POLA1 SPTAN1 SPTBN1 MYO18A GLUD2 DNAH9 | 2.25e-05 | 354 | 177 | 12 | CID000024584 |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; HL60; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 3050_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 6603_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 5467_DN | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 7325_UP | |
| Drug | verapamil | MYH2 MYH3 MYH8 MYH10 CYP2C19 CYP2C9 MYH7B MYO18A APOB PRPF6 APOE RYR3 ABCG2 GNRH1 | 3.12e-05 | 490 | 177 | 14 | CID000002520 |
| Drug | Acenocoumarol | 3.75e-05 | 9 | 177 | 3 | ctd:D000074 | |
| Drug | K-Cl | MYH2 MYH3 MYH8 MYH10 FMR1 MYH7B POLA1 KSR2 MYO18A AASDH RYR3 SLC4A1 GSDME GNRH1 SMG6 | 3.91e-05 | 567 | 177 | 15 | CID000004873 |
| Drug | 5-fluorocytidine | 3.93e-05 | 25 | 177 | 4 | CID000016861 | |
| Drug | methylpropylnitrosamine | 3.93e-05 | 25 | 177 | 4 | CID000013545 | |
| Drug | 4-epidoxorubicin | MYH2 MYH3 MYH8 MYH10 MYH7B POLA1 SPTBN1 MYO18A TRIM34 TTPA GSDME TRIM28 ABCG2 CDC25C ZBED1 GNRH1 MAD2L1 SMG6 | 4.51e-05 | 788 | 177 | 18 | CID000001690 |
| Drug | Ro 31-8959 | 4.99e-05 | 84 | 177 | 6 | CID000060787 | |
| Drug | Clorgyline | 5.26e-05 | 168 | 177 | 8 | ctd:D003010 | |
| Drug | dibenzylfluorescein | 6.01e-05 | 2 | 177 | 2 | ctd:C558664 | |
| Drug | Met-met-met | 6.01e-05 | 2 | 177 | 2 | CID003082062 | |
| Drug | SM-2 | 6.08e-05 | 87 | 177 | 6 | CID000486033 | |
| Drug | struvite | 7.28e-05 | 11 | 177 | 3 | CID006335612 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.52e-09 | 10 | 171 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.52e-09 | 10 | 171 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.52e-09 | 10 | 171 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.52e-09 | 10 | 171 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.52e-09 | 10 | 171 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.52e-09 | 10 | 171 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.52e-09 | 10 | 171 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.52e-09 | 10 | 171 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.72e-09 | 12 | 171 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.72e-09 | 12 | 171 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 7.64e-09 | 13 | 171 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.77e-08 | 15 | 171 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 3.48e-07 | 48 | 171 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | cholesteryl ester 18:3 measurement | 3.44e-06 | 40 | 171 | 5 | EFO_0010346 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.64e-06 | 71 | 171 | 6 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 7.31e-06 | 80 | 171 | 6 | DOID:12930 (implicated_via_orthology) | |
| Disease | bile duct cancer (is_implicated_in) | 3.34e-05 | 2 | 171 | 2 | DOID:4606 (is_implicated_in) | |
| Disease | response to statin, LDL cholesterol change measurement | 8.27e-05 | 15 | 171 | 3 | EFO_0007804, GO_0036273 | |
| Disease | docosahexaenoic acid measurement, fatty acid measurement | 8.46e-05 | 40 | 171 | 4 | EFO_0005110, EFO_0007761 | |
| Disease | brain measurement, neuroimaging measurement | PDXDC1 SOX5 KTN1 SPTBN1 MCTP1 CEP112 ADAMTS20 MACF1 ABCG2 PLEC ZSWIM4 SMG6 | 9.40e-05 | 550 | 171 | 12 | EFO_0004346, EFO_0004464 |
| Disease | platelet measurement | 9.86e-05 | 315 | 171 | 9 | EFO_0005036 | |
| Disease | low density lipoprotein cholesterol measurement, lipid or lipoprotein measurement | 9.98e-05 | 3 | 171 | 2 | EFO_0004611, EFO_0005105 | |
| Disease | X-21258 measurement | 9.98e-05 | 3 | 171 | 2 | EFO_0800802 | |
| Disease | Ataxia with vitamin E deficiency | 9.98e-05 | 3 | 171 | 2 | C1848533 | |
| Disease | docosahexaenoic acid measurement | 1.01e-04 | 127 | 171 | 6 | EFO_0007761 | |
| Disease | neuroimaging measurement | PDXDC1 SOX5 MYH10 KRT17 SZT2 KTN1 SPTBN1 KSR2 APOE CEP112 ADAMTS20 MACF1 UMPS ABCG2 PLEC ZSWIM4 SMG6 | 1.69e-04 | 1069 | 171 | 17 | EFO_0004346 |
| Disease | cholesteryl ester 20:3 measurement | 1.88e-04 | 49 | 171 | 4 | EFO_0010347 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 2.23e-04 | 94 | 171 | 5 | EFO_0008595, EFO_0010351 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 2.46e-04 | 96 | 171 | 5 | EFO_0004529, EFO_0008595 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 2.84e-04 | 99 | 171 | 5 | EFO_0004574, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 2.84e-04 | 99 | 171 | 5 | EFO_0004639, EFO_0008595 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.95e-04 | 55 | 171 | 4 | C0079744 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.30e-04 | 5 | 171 | 2 | C0600066 | |
| Disease | nuclear receptor-binding protein measurement | 3.30e-04 | 5 | 171 | 2 | EFO_0801854 | |
| Disease | Phyllodes Tumor | 3.30e-04 | 5 | 171 | 2 | C0010701 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 3.57e-04 | 104 | 171 | 5 | EFO_0008591, EFO_0008595 | |
| Disease | phospholipids:total lipids ratio | 3.75e-04 | 227 | 171 | 7 | EFO_0020946 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 3.75e-04 | 227 | 171 | 7 | EFO_0004346, EFO_0010736 | |
| Disease | eosinophil count | UACA ZNF177 SPTBN1 TNFRSF14 SAMD12 APOE ELMO1 RAD50 SH3PXD2B PPP4C MDN1 AKAP9 HELZ2 MED12L RAB7A AP1G2 MAFB PLEC VAMP8 CDC25C | 4.11e-04 | 1488 | 171 | 20 | EFO_0004842 |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 4.12e-04 | 60 | 171 | 4 | EFO_0021898 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 4.67e-04 | 62 | 171 | 4 | EFO_0022263 | |
| Disease | coronary artery disease, factor VII measurement | 4.81e-04 | 111 | 171 | 5 | EFO_0001645, EFO_0004619 | |
| Disease | Vision Disability | 4.93e-04 | 6 | 171 | 2 | C3489704 | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 4.93e-04 | 6 | 171 | 2 | EFO_0800611 | |
| Disease | Metamorphopsia | 4.93e-04 | 6 | 171 | 2 | C0271185 | |
| Disease | Micropsia | 4.93e-04 | 6 | 171 | 2 | C0233769 | |
| Disease | Macropsia | 4.93e-04 | 6 | 171 | 2 | C0233771 | |
| Disease | Premature Ovarian Failure 1 | 4.93e-04 | 6 | 171 | 2 | C4552079 | |
| Disease | Gonadotropin-Resistant Ovary Syndrome | 4.93e-04 | 6 | 171 | 2 | C0086367 | |
| Disease | Hypergonadotropic Ovarian Failure, X-Linked | 4.93e-04 | 6 | 171 | 2 | C3494522 | |
| Disease | Vision Disorders | 4.93e-04 | 6 | 171 | 2 | C0042790 | |
| Disease | Hemeralopia | 4.93e-04 | 6 | 171 | 2 | C0018975 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 4.97e-04 | 63 | 171 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 5.05e-04 | 27 | 171 | 3 | EFO_0022238 | |
| Disease | factor VIII measurement, coronary artery disease | 5.22e-04 | 113 | 171 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 6.36e-04 | 118 | 171 | 5 | EFO_0010119 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 6.36e-04 | 118 | 171 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | refractive error | 6.60e-04 | 326 | 171 | 8 | MONDO_0004892 | |
| Disease | LDL cholesterol change measurement | 6.88e-04 | 7 | 171 | 2 | EFO_0007804 | |
| Disease | Visual Impairment | 6.88e-04 | 7 | 171 | 2 | C3665347 | |
| Disease | neuronal pentraxin-2 measurement | 6.88e-04 | 7 | 171 | 2 | EFO_0801834 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 7.82e-04 | 71 | 171 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | microcephaly (implicated_via_orthology) | 8.38e-04 | 32 | 171 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | low tension glaucoma (is_implicated_in) | 9.14e-04 | 8 | 171 | 2 | DOID:13544 (is_implicated_in) | |
| Disease | response to statin, low density lipoprotein cholesterol measurement | 9.14e-04 | 8 | 171 | 2 | EFO_0004611, GO_0036273 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 9.14e-04 | 8 | 171 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | Hereditary spherocytosis | 9.14e-04 | 8 | 171 | 2 | C0037889 | |
| Disease | Aqueductal Stenosis | 9.14e-04 | 8 | 171 | 2 | C2936786 | |
| Disease | polyunsaturated fatty acid measurement | 1.02e-03 | 131 | 171 | 5 | EFO_0010733 | |
| Disease | Kartagener Syndrome | 1.09e-03 | 35 | 171 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.09e-03 | 35 | 171 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 1.09e-03 | 35 | 171 | 3 | C4317124 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.11e-03 | 78 | 171 | 4 | EFO_0022187 | |
| Disease | Distal arthrogryposis | 1.17e-03 | 9 | 171 | 2 | cv:C0265213 | |
| Disease | Cardiovascular Diseases | 1.19e-03 | 36 | 171 | 3 | C0007222 | |
| Disease | carotid artery intima media thickness | 1.31e-03 | 450 | 171 | 9 | EFO_0007117 | |
| Disease | phosphatidylcholine measurement | 1.39e-03 | 284 | 171 | 7 | EFO_0010226 | |
| Disease | Muscle Weakness | 1.46e-03 | 10 | 171 | 2 | C0151786 | |
| Disease | degree of unsaturation measurement | 1.50e-03 | 39 | 171 | 3 | EFO_0022261 | |
| Disease | Hypercholesterolemia | 1.50e-03 | 39 | 171 | 3 | C0020443 | |
| Disease | Malignant neoplasm of breast | RAP1GAP SPTAN1 KTN1 SMC6 KMT2D AKAP9 TAX1BP1 TENM1 MACF1 UMPS ABCG2 DMD DNAH9 MED12 GOLGB1 | 1.53e-03 | 1074 | 171 | 15 | C0006142 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.55e-03 | 144 | 171 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.60e-03 | 291 | 171 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 1.61e-03 | 40 | 171 | 3 | EFO_0004746 | |
| Disease | X-11308 measurement | 1.77e-03 | 11 | 171 | 2 | EFO_0800693 | |
| Disease | cytochrome p450 3a4 measurement | 1.77e-03 | 11 | 171 | 2 | EFO_0020303 | |
| Disease | beta thalassemia (is_marker_for) | 1.77e-03 | 11 | 171 | 2 | DOID:12241 (is_marker_for) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.92e-03 | 222 | 171 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 1.99e-03 | 43 | 171 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | retinal nerve fibre layer thickness measurement | 1.99e-03 | 43 | 171 | 3 | EFO_0600004 | |
| Disease | triacylglycerol 56:6 measurement | 1.99e-03 | 43 | 171 | 3 | EFO_0010433 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.99e-03 | 43 | 171 | 3 | EFO_0022290 | |
| Disease | sexual dimorphism measurement | PDXDC1 SOX5 KRT17 RASGRF1 DNAAF4 APOB AIP APOE TRIP11 SLC4A1 FER1L4 CEP250 MACF1 PLEC AKAP7 | 2.03e-03 | 1106 | 171 | 15 | EFO_0021796 |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.06e-03 | 225 | 171 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | open-angle glaucoma (is_implicated_in) | 2.12e-03 | 12 | 171 | 2 | DOID:1067 (is_implicated_in) | |
| Disease | thymol sulfate measurement | 2.12e-03 | 12 | 171 | 2 | EFO_0021170 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:3) in blood serum | 2.12e-03 | 12 | 171 | 2 | OBA_2045115 | |
| Disease | integral membrane protein 2B measurement | 2.12e-03 | 12 | 171 | 2 | EFO_0802634 | |
| Disease | cognitive impairment measurement | 2.13e-03 | 44 | 171 | 3 | EFO_0007998 | |
| Disease | total lipids in very small VLDL measurement | 2.27e-03 | 45 | 171 | 3 | EFO_0022156 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DRVRNLQSEVEGVKN | 11 | Q9BV40 | |
| VRRDLQKVRQEVQPA | 286 | Q17RC7 | |
| IAEQQRRQEKIQAVL | 1216 | Q86US8 | |
| TENVDKRQIILDLQI | 256 | A0FGR8 | |
| DKPQIQEVREQRVTG | 1071 | P48751 | |
| RQIQEKTDIIDRLEQ | 1936 | Q99996 | |
| ELIKQQRLNRLVEGT | 546 | Q92556 | |
| ENERKAEVVQVIRNP | 311 | Q9H6F5 | |
| EVRAKLEEQAQQIRL | 256 | P02649 | |
| IGKQNSLEERIRQQE | 536 | Q8IVF6 | |
| RLQAEKSVLEIQGQE | 1031 | A6NC98 | |
| AQIQEVKEQRISGLL | 751 | P02730 | |
| GIKILQNAIIQQDER | 101 | Q9P0M2 | |
| QELRDLLTEGKQRQE | 106 | Q7Z2Y8 | |
| LLTEGKQRQEEAVRT | 111 | Q7Z2Y8 | |
| GTLRKQEVDLQQLIR | 116 | O60443 | |
| EKNERINRVIQELGL | 156 | Q9UNQ0 | |
| LIEEIRGAKTQAQER | 11 | O75843 | |
| KEEQLTRVTEVQRLQ | 581 | Q8N8E3 | |
| RLKEQQEVAAAVIQR | 1066 | O94983 | |
| GKRLNIELVQQVAEE | 451 | Q4L235 | |
| IKEIENQLRRTSIQE | 196 | Q9Y5C1 | |
| QAQKVLRDSVQRLEV | 121 | Q6UXH0 | |
| VKELRTVVQERNDAQ | 571 | Q8IYA2 | |
| EEAVRRQKLLEQSIQ | 1356 | P11532 | |
| VQQNIDIIGNEILKR | 81 | Q8N3C7 | |
| EKENQILGITLRQRD | 616 | Q49A88 | |
| ERINSTNRQEKEILI | 806 | P59510 | |
| ARLREDGIQKRVIQE | 6 | O00170 | |
| QELSRVQEEVKLRQQ | 1531 | Q96SN8 | |
| AELQKRVEGLQREVA | 626 | Q13613 | |
| VVLGNKIDLENRQVA | 121 | P51149 | |
| KLQRQDEELLGRVQS | 1251 | Q9H0J4 | |
| KVAQETDVRAQIRLQ | 71 | Q92878 | |
| VNVEGQSRLNEKILE | 106 | O43665 | |
| QTDVEGRVVENISKR | 61 | Q9UKC9 | |
| LAGRVRKQEEIDVIQ | 1306 | Q9NU22 | |
| QKVTRQEREEALVRG | 121 | Q9H2I8 | |
| IISGKDNRQRDTVVE | 841 | Q6DN14 | |
| EVEQQIKQRGRAVEV | 426 | Q86YW9 | |
| QVEQLKQEVSRLARE | 276 | Q9Y5Q3 | |
| EELRQVSGQLLEERK | 371 | Q9Y6D9 | |
| QKAIQDEIRSVIRQI | 121 | Q13257 | |
| RIQELQRAQEQLGKE | 101 | Q8WWB3 | |
| IQKEIEELLRGVQQR | 276 | Q9Y692 | |
| ERISLQQELSRVKQE | 451 | Q13439 | |
| DIQVGDLIIVEKNQR | 231 | O43861 | |
| RDILGNRDVQVKSVE | 1336 | Q9Y3R5 | |
| RVQGEAQKVERLIEA | 616 | Q6DN90 | |
| VVLGNKIDLSEQRQV | 116 | Q9NYS0 | |
| IVLDVNKTRQIAQEI | 756 | Q6VAB6 | |
| QELKNAVETDQRVRV | 1191 | O60318 | |
| RKVAERLDQGLQEVE | 546 | A9Z1Z3 | |
| QGRLQEELRKVSQER | 136 | Q6KB66 | |
| VVDNRNQVVGLVTRK | 771 | P51798 | |
| ERLQNILEQIVSVGK | 216 | P48058 | |
| ELGEQVDSLQRVRQK | 1251 | A7E2Y1 | |
| GQEDLKEQLAIVERR | 1666 | P13535 | |
| VAELGEQIDNLQRVK | 1206 | Q9UKX2 | |
| RIQLELNQVKSEVDR | 1566 | Q9UKX2 | |
| INVRKRNVESGEEEL | 71 | Q96HS1 | |
| EVVRKGIQEAQVELQ | 611 | Q6P996 | |
| FKQGEQIEIIRITDN | 531 | O15117 | |
| GIEELILRIQESKRQ | 541 | Q6ZR08 | |
| VRLNNVQEGKQIETL | 21 | Q5S007 | |
| TEGILQKLQRSVEQE | 1146 | Q86UP2 | |
| ELSKLQQRLGREVEE | 371 | P36776 | |
| LREIEQQIKERGQAV | 421 | Q93074 | |
| QRLVEQLKLEAGVER | 11 | P50151 | |
| QVVQRIKAVEGQTRL | 71 | Q15599 | |
| NRRRQEGIKIVLEDI | 111 | E9PIF3 | |
| NEKVQEVLRETVNRI | 291 | Q8NGM8 | |
| ADLEILQQKVAGVQR | 46 | A6NF36 | |
| NIQKRLIEIGENVLN | 1111 | P09884 | |
| DEQLQKLGVQVREEL | 96 | O14745 | |
| KLGVQVREELLRAQE | 101 | O14745 | |
| KVDLRRQQISQAVEE | 16 | Q8N8X9 | |
| VKLEVQRQLIGTQRE | 2106 | Q9UPN3 | |
| SKVQEGERQLREQIA | 451 | P30307 | |
| VNKELEQLQGLVEER | 286 | A1A4V9 | |
| RLEVENQAKRLLEQG | 236 | Q9UP83 | |
| DKIREVTQRLNGEIQ | 2441 | P04114 | |
| SGVVRVRIEAENEKN | 311 | Q06787 | |
| EARETVQIINKEEQG | 4101 | Q4G0P3 | |
| RQVRTIVEEVQDGKV | 406 | Q04695 | |
| GEEIKELQQRLGEVQ | 51 | Q6ZUS6 | |
| AKVQEEIERVIGRNR | 321 | P33261 | |
| AETEQGLKRELQVLR | 2331 | O15078 | |
| LIEKERNGETINTRL | 186 | Q13616 | |
| QVVRVVRQEERKGLI | 236 | Q8NCL4 | |
| SQRKQQLEVELRQVT | 1441 | P15924 | |
| EVETLRGQIQELEKQ | 1436 | Q9BV73 | |
| VQEREQKLTVQREQI | 1496 | Q9BV73 | |
| IKELEGQRETQRVAL | 1576 | Q9BV73 | |
| VRELQLTLAQKEQEI | 2096 | Q9BV73 | |
| LTQREVQAKQLELEI | 501 | Q92828 | |
| NIVEKERVQRITQET | 241 | Q96H22 | |
| IVQIDAEKIRNVIQG | 401 | Q8WXU2 | |
| LSDGQRREQQEIKVV | 96 | Q08554 | |
| VRTALQQQEEEIKAR | 366 | Q5T7N3 | |
| VDRAVNRIKEIITNG | 171 | Q7Z7F0 | |
| QKIQEVGEITNLRVN | 206 | Q13751 | |
| KFNVEDGEIVQQVRV | 201 | Q8N766 | |
| TKDRIISEINRLQQE | 681 | Q9Y6C2 | |
| VRNEVKSQGLVDNRE | 2921 | Q9NYC9 | |
| AKVQEEIERVIGRNR | 321 | P11712 | |
| RKELERVAGELQSQV | 311 | I6L899 | |
| QEIVKEVGQLAETQR | 46 | P01148 | |
| LIQEKGEASQRRELV | 1846 | Q9BYK8 | |
| TQESEEQKRNRVRGI | 91 | P49448 | |
| KVVRELQAQIAELQE | 1111 | P35580 | |
| NQTQLREIAGEEKRV | 576 | A6NMZ7 | |
| VQDLRVAREKGSQIQ | 236 | Q3KNS1 | |
| LEVREKLQGQDSERV | 96 | Q9UKS6 | |
| AEQEKDQLRTQVVRL | 136 | Q96CV9 | |
| KAERELEGQIQRLNT | 146 | A7E2F4 | |
| EVSVDRVKQLALRQQ | 386 | Q96C34 | |
| QRQKRRTTQLEEGEV | 2501 | Q5T011 | |
| QLQLRVVKEGDEEIN | 236 | Q8WVZ7 | |
| REARIKVLEEQINEG | 371 | O95219 | |
| DELVQQKQLVRELIS | 221 | Q9BYJ4 | |
| LRKAEEQVQATRQEV | 356 | Q86VP1 | |
| IEERRQGLEQFINKI | 116 | Q9UMY4 | |
| DLQVRVQAEKGLQRD | 566 | Q6ZMZ3 | |
| QDEIVQGTRRRTQKD | 866 | O15061 | |
| LKEQGQLVRQDEFVV | 921 | Q58EX7 | |
| LQHGTEEQQEEVRKR | 886 | O94906 | |
| IENVVRNILKGQDVD | 901 | Q8IVG5 | |
| TRQIEDLRGQLEKET | 1321 | Q9Y2K3 | |
| RQLVKEIGREIQQLS | 86 | Q96ME1 | |
| IGIENIQEVQEKRES | 501 | P47736 | |
| IAETDERKVNRIQQV | 1441 | Q9UKZ4 | |
| KVREEVRNLQLLTQG | 141 | Q8N8I0 | |
| QVELEEKTRLINQVL | 91 | Q9UIL1 | |
| VAELGEQIDNLQRVK | 1201 | P11055 | |
| VQQKETLGAQREAIR | 71 | P47972 | |
| RVRKEVGEVSVLVNN | 131 | Q8IZV5 | |
| VAKQLRQQIEDGEIE | 156 | Q13972 | |
| KRIEELGQRLQEQNE | 416 | Q86YF9 | |
| SEIQLRKEVETRQQL | 386 | Q8N0Z3 | |
| RKEVETRQQLEQVLG | 391 | Q8N0Z3 | |
| SKGDIIILRRQVDEN | 156 | Q7Z6J0 | |
| RLVLEKNVQLEEQIS | 251 | O00463 | |
| NEEKINAVVETGRRL | 1221 | Q01082 | |
| EKAIRNVQDIITRNQ | 181 | Q7Z624 | |
| RGEINFKDIQVIVNV | 196 | P13591 | |
| VKTVQQEEIVRGDVR | 826 | A4UGR9 | |
| AREQEEKLQRVRGLI | 236 | Q9BYV2 | |
| QVELELQQIEQKSIR | 86 | Q8N1B4 | |
| RVEQKEAEVGELQRR | 221 | Q9NNX1 | |
| DRQLKELQEQGEIRI | 186 | P49842 | |
| VRLEGTNVQEAQKIL | 391 | Q96I99 | |
| LLGQNEVEQRQRKVV | 46 | Q9HA47 | |
| EVEQRQRKVVILSQD | 51 | Q9HA47 | |
| EETDVNRNKLRINIG | 401 | Q5TCY1 | |
| RKTVQLIQALEEVQE | 496 | Q12768 | |
| VEIVRQSLQGRNTKV | 121 | Q7Z392 | |
| VDQEQLKTDERGILQ | 66 | Q13360 | |
| KTLDQIRTIERNQEI | 171 | O00743 | |
| ETRRQELLEKITEGQ | 106 | Q9BSV6 | |
| VERTKEGEALVQQRE | 2686 | Q15413 | |
| LIVRERGEKVLQNDE | 3716 | Q15413 | |
| NLERGAVVEVIQKNL | 241 | A1X283 | |
| IGKEEIQQRLAQFVE | 1836 | Q13813 | |
| RGKAEVNQETIQRLL | 11 | Q9UHA2 | |
| QEVIRSVLEAQRGNK | 246 | Q9H0E2 | |
| AETVGRVKRFIQENV | 191 | P11172 | |
| QIHQGEERLTELKRQ | 236 | Q96SB8 | |
| GQEAEQDRVVLKRVL | 311 | Q9Y2I9 | |
| DGNQVVRDKITELRV | 121 | Q9Y279 | |
| EGVRRKQEELQQLEQ | 2701 | Q15149 | |
| ELIVQEVETQRNGIK | 141 | P49638 | |
| NKTEISVRGQDRLII | 531 | Q9BZ95 | |
| QLEAKVRGLERQVEE | 211 | Q9BVC6 | |
| TELQRRIQESAKQIE | 1301 | Q9BZF9 | |
| QALRKNEILRQTIEE | 836 | Q15643 | |
| VQRKRQEAEGEATVI | 241 | Q92956 | |
| RREQQVLDGKVAVVN | 471 | P35711 | |
| QQVENRVVEEAKGLL | 491 | O96006 | |
| NDQIRELQTIIRDKT | 116 | Q96BW1 | |
| IQTLDQIRTIDRKQE | 171 | P60510 | |
| QLRKVQEGAQILQER | 221 | Q9BVG3 | |
| ADVVQQAKEIIRDRQ | 51 | Q8N6V9 | |
| GEESRVQVLKNEVRR | 21 | O95411 | |
| IRQVSDVQKRVQVDV | 281 | Q13263 | |
| ELDERLVQVLRKQAG | 506 | Q9H7M6 | |
| RIQHVVEAVRQEKQE | 1631 | Q14789 | |
| EVKQIASIIQRGERL | 5161 | O14686 | |
| PEIQRVRAQEREQIK | 116 | Q14CN4 | |
| VGQLTEQRKDTLVRQ | 826 | Q5VV43 | |
| KRNDQDQETITGLRV | 6486 | P20929 |